Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             984 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A004 Adrenomedullin inhibited by acute saline volume expansion in rats Zimmerman, R.S.
1998
11 4S1 p. 31A-
1 p.
artikel
2 A002 Alterations in endothelial-dependent and independent vessel relaxation during DOCA-Salt hypertension Kawabe, T.
1998
11 4S1 p. 84A-
1 p.
artikel
3 A006 Ang II-induced phosphorylation of the endogenous AT1 receptor in bovine adrenal glomerulosa cells Smith, R.D.
1998
11 4S1 p. 32A-
1 p.
artikel
4 A008 Angiotensin-converting enzyme gene polymorphism does not overtly influence left ventricular hypertrophy and aortic stiffness in hypertensives Karpanou, E.A.
1998
11 4S1 p. 138A-
1 p.
artikel
5 A030 Angiotensin II-activated map kinase pathways are associated with sustained vascular smooth muscle contraction Touyz, R.M.
1998
11 4S1 p. 38A-
1 p.
artikel
6 A007 Angiotensin-(1–7) infusion attenuates angiotensin II-induced prostacyclin release from kidney slices Diz, D.I.
1998
11 4S1 p. 32A-
1 p.
artikel
7 A022 ANP is not degraded from human lungs: Evidence from a new kinetic circulatory approach Iervasi, Giorgio
1998
11 4S1 p. 36A-
1 p.
artikel
8 A011 Anti hypertrophic effect of bay 10-6734, a new angiotensin II receptor antagonist Iouzalen, L.
1998
11 4S1 p. 33A-
1 p.
artikel
9 A020 Apoptosis in fibroblasts populations during the establishment of hypertension in the spontaneously hypertensive rat Klett, Christoph P.R.
1998
11 4S1 p. 35A-
1 p.
artikel
10 A001 beta-3-adrenergic receptor gene polymorphism and metabolic syndrome in essential hypertensive patients Fernandez-Movano, A.
1998
11 4S1 p. 137A-
1 p.
artikel
11 A006 Bimodal pressor response to phenylephrine in hypokalemic rats suggests differential adaptive response to low K+ diet Mileticli, D.J.
1998
11 4S1 p. 138A-
1 p.
artikel
12 Absence of the “Yin/Yang effect” for AT1 and AT2 angiotensin II subtype receptors in the modulation of salt-regulating hormone secretion in the rat Volpe, M.
1998
11 4S1 p. 18A-
1 p.
artikel
13 Abstract: Introduction: Overview of the management of hypertension in special populations Saunders, Elijah
1998
11 4S1 p. 255A-
1 p.
artikel
14 A014 Calcium channel blocker isradipine infusion induces the acetylcholine- vasodilation in hypertensive patients Perticone, F.
1998
11 4S1 p. 87A-
1 p.
artikel
15 A025 Candesartan, an insurmountable antagonist of angiotensin II mediated contractile effects in isolated vascular preparations: A comparison with irbesartan, losartan and its active metabolite (EXP 3174) Morsing, P.
1998
11 4S1 p. 37A-
1 p.
artikel
16 A024 Candesartan causes a long-lasting antagonism of the angiotensin II receptor mediated contractile effects in isolated vascular preparations: A comparison with losartan and its active metabolite (EXP 3174) Abrahamsson, T.
1998
11 4S1 p. 36A-
1 p.
artikel
17 A014 Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells in response to ET-1 Morita, T.
1998
11 4S1 p. 34A-
1 p.
artikel
18 A005 Cardiac upregulation of preproendothelin-1 synthesis in spontaneously hypertensive rats is an early event preceding hypertension Seccia, T.M.
1998
11 4S1 p. 32A-
1 p.
artikel
19 A035 Characterization of endothelin receptors and endothelin synthesis in porcine kidney Bäcker, A.
1998
11 4S1 p. 39A-
1 p.
artikel
20 A003 Chronic effects of ace-inhibition and endothelin (ETA) receptor antagonism on blood pressure Münter, K.
1998
11 4S1 p. 31A-
1 p.
artikel
21 Adaptive changes of tissue ace expression to dietary electrolytes Danilov, S.M.
1998
11 4S1 p. 13A-
1 p.
artikel
22 A002 Differential angiotensin II receptor gene expression: A growth induced response Fouletier, C.
1998
11 4S1 p. 31A-
1 p.
artikel
23 A001 Differential changes in vascular e-NOS and i-NOS during doca-salt hypertension Kawabe, T.
1998
11 4S1 p. 84A-
1 p.
artikel
24 A011 Differential effects of losartan and doxazosin on vascular function in aged spontaneously hypertensive rats Maeso, R.
1998
11 4S1 p. 86A-
1 p.
artikel
25 A008 Differential pathways for angiotensin-(1–7) metabolism in the lung and kidney Jones, A.G.
1998
11 4S1 p. 32A-
1 p.
artikel
26 Adipose large artery infiltration and endothelial dysfunction represent early cardiovascular abnormalities in normotensive alcohol abusers Maiorano, G.
1998
11 4S1 p. 25A-
1 p.
artikel
27 A017 Distinct mechanisms of modulation of neuronal expression of angiotensin II receptor subtypes Li, J.P.
1998
11 4S1 p. 35A-
1 p.
artikel
28 β2 adrenoceptor polymorphism and vascular reactivity in human resistance and capacitance vessels Cockcroft, John R.
1998
11 4S1 p. 14A-
1 p.
artikel
29 Adrenomedulin and oubain in experimental cardiac hypertrophy Tóth, M.
1998
11 4S1 p. 7A-
1 p.
artikel
30 Adverse effect of salt loading on indices of diastolic filling in low renin hypertension Shiels, P.
1998
11 4S1 p. 24A-
1 p.
artikel
31 A012 Elevated urinary albumin excretion: A marker of abnormal systemic microvascular permeability? Pedrinelli, R.
1998
11 4S1 p. 86A-
1 p.
artikel
32 A007 Endothelial activation in obese patients with or without essential hypertension Ferri, C.
1998
11 4S1 p. 85A-
1 p.
artikel
33 A008 Endothelial dysfunction and dyslipidemia in essential hypertensive patients Ferri, C.
1998
11 4S1 p. 85A-
1 p.
artikel
34 A001 Evidence for differential autocrine regulation of natriuretic peptide receptor gene expression by locally synthesised natriuretic peptides Mistry, S.
1998
11 4S1 p. 31A-
1 p.
artikel
35 A005 Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria Gasic, S.
1998
11 4S1 p. 85A-
1 p.
artikel
36 A002 Genomic cloning and generation of a targeting construct of T594M mutation in the β-subunit of the amiloride sensitive channel Su, Y.R.
1998
11 4S1 p. 137A-
1 p.
artikel
37 A015 Increased atrial natriuretic peptide and decreased blood pressure in fasting obese zucker rats Sarzani, Riccardo
1998
11 4S1 p. 34A-
1 p.
artikel
38 A028 Increasing the expression of endothelin converting enzyme and endothelin receptor subtypes in human myocardium with congestive heart failure Song, H.
1998
11 4S1 p. 37A-
1 p.
artikel
39 A031 Inhibition of ANP-C receptor expression and associated adenylyl cyclase activity by phosphoro-thioate antisense oligodeoxynucleotides Anand-Srivastava, M.B.
1998
11 4S1 p. 38A-
1 p.
artikel
40 A029 Inhibition of mitogen-activated protein kinase attenuates and II-induced alkalinization and contraction in SHR vascular smooth muscle cells Touyz, R.M.
1998
11 4S1 p. 38A-
1 p.
artikel
41 A016 Inhibitory effects of PD 155080 on endotelin-1 receptors in human heart Vanni, S.
1998
11 4S1 p. 34A-
1 p.
artikel
42 A004 Interaction of the renin-angiotensin- and the endothelin-system and its effect on blood pressure Münter, K.
1998
11 4S1 p. 84A-
1 p.
artikel
43 A016 Kinins and hyperhomocysteinemia in fructose-induced diabetic rats Nolly, H.
1998
11 4S1 p. 87A-
1 p.
artikel
44 A013 LDL-cholesterol lowering, transcapillary leakage of albumin and acetycholine-mediated vasodilatation in atherosclerotic patients Dell'Omo, G.
1998
11 4S1 p. 87A-
1 p.
artikel
45 A010 Left ventricular mass and endothelium-dependent vasodilation in never treated hypertensives Perticone, F.
1998
11 4S1 p. 86A-
1 p.
artikel
46 Alpha-adducin and salt sensitivity Bianchi, G.
1998
11 4S1 p. 243A-
1 p.
artikel
47 Altered responsiveness to angiotensin II in aging SHR causes glomerular hypertension Tolbert, E.
1998
11 4S1 p. 1A-
1 p.
artikel
48 Ambulatory pulse pressure: A strong prognostic marker in essential hypertension Verdecchia, P.
1998
11 4S1 p. 23A-
1 p.
artikel
49 A034 Modulation of central vasopressin by blockade of the renin-angiotensin system in left ventricular hypertrophy Muders, F.
1998
11 4S1 p. 39A-
1 p.
artikel
50 A026 Modulation of renal blood flow by endogenous endothelin-1 in conscious rabbits with low cardiac output state Muders, F.
1998
11 4S1 p. 37A-
1 p.
artikel
51 A027 Modulation of structural remodeling and endothelin-1 expression in small mesenteric arteries by vasopressin in the doca-salt rat Intengan, H.D.
1998
11 4S1 p. 37A-
1 p.
artikel
52 A007 MRI analysis of left ventricular mass in essential hypertensives and molecular variants of the renin angiotensin system Sharma, Pankaj
1998
11 4S1 p. 138A-
1 p.
artikel
53 A003 Na+/Mg++ exchange in smooth muscle cells in SHR. Kisters, K.
1998
11 4S1 p. 137A-
1 p.
artikel
54 Angiotensin I-converting enzyme (ACE): Sequence and consequenses Corvol, Pierre
1998
11 4S1 p. 238A-
1 p.
artikel
55 Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors Touyz, R.M.
1998
11 4S1 p. 11A-
1 p.
artikel
56 Angiotensin II promotes ICAM-1 expression in vitro and soluble ICAM-1 secretion in vivo Pastore, L.
1998
11 4S1 p. 27A-
1 p.
artikel
57 Angiotensin peptides: Critical review of functional aspects Campbell, D.J.
1998
11 4S1 p. 240A-
1 p.
artikel
58 Angiotensin receptor blockers and left ventricular hypertrophy Thürmann, Petra A.
1998
11 4S1 p. 252A-
1 p.
artikel
59 A novel salt sensitive hypertensive model induced by sensory denervation Wang, D.H.
1998
11 4S1 p. 29A-
1 p.
artikel
60 A005 plasma renin activity levels are related to the angiotensinogen gene M235T polymorphism Fernandez-Arcas, N.
1998
11 4S1 p. 138A-
1 p.
artikel
61 A009 Pravastatin activates endothelial nitric oxide synthase independent of its lipid lowering actions Kaesemeyer, W.H.
1998
11 4S1 p. 86A-
1 p.
artikel
62 A009 Prostaglandins mediate the anti-hypertensive effects of angiotensin-(1–7) during chronic blockade of the renin-angiotensin system Yamada, K.
1998
11 4S1 p. 33A-
1 p.
artikel
63 Are drugs which block the renin angiotensin system safe and effective in patients with renal insufficiency? Weir, M.R.
1998
11 4S1 p. 250A-
1 p.
artikel
64 A012 Reduction of neointima in transgenic (mRen2)27 hypertensive rats is augmented by dual lisinopril/losartan administration Strawn, W.B.
1998
11 4S1 p. 33A-
1 p.
artikel
65 A006 Relationship between tumor necrosis factor alpha (TNF-α) levels and acute cardiogenic pulmonary edema Somasundaram, P.
1998
11 4S1 p. 85A-
1 p.
artikel
66 Ascorbic acid enhances endothelium-dependent relaxation in sub-cutaneous resistance arteries in ischaemic heart disease Tyrrell, J.R.J.
1998
11 4S1 p. 27A-
1 p.
artikel
67 A010 Selective effects of angiotensin II (AII) and endothelin (ET) in regional hemodynamics and renal function in anesthetized dogs Gomez-Alamillo, C.
1998
11 4S1 p. 33A-
1 p.
artikel
68 ASH XIII special symposia May 13 to 16, 1998 1998
11 4S1 p. XXI-XXIX
nvt p.
artikel
69 A013 Spironolactone increases survival in mREN2(27) transgenic rats with malignant hypertension Diz, D.I.
1998
11 4S1 p. 34A-
1 p.
artikel
70 Assessment of left ventricular diastolic function in a group of young subjects with borderline to mild hypertension. The harvest study Vriz, O.
1998
11 4S1 p. 2A-
1 p.
artikel
71 A023 The circolatory model in metabolic studies of rapidly renewed hormones: Application to ANP kinetics Pilo, Alessandro
1998
11 4S1 p. 36A-
1 p.
artikel
72 A009 The DD genotype of the angiotensin-converting enzyme gene is related to hypercholesterolemia in hypertensive patients Karpanou, E.A.
1998
11 4S1 p. 139A-
1 p.
artikel
73 A033 The effects of angiotensin II (AII), endothelin-1 (ET1) and protein kinase C (PKC) inhibitor on DNA synthesis and cytosolic calcium (Ca++) mobilization in VSMC's of WKY and SHR Rosen, B.
1998
11 4S1 p. 39A-
1 p.
artikel
74 A004 The interaction between a1166c AT1 angiotensin II receptor and M235T from angiotensinogen gene polymorphisms shows a high frequency in hypertensive individuals Muñoz, E.
1998
11 4S1 p. 137A-
1 p.
artikel
75 A021 The relationships between blood pressure, renal volume and vasoactive hormones Campbell, S.K.
1998
11 4S1 p. 36A-
1 p.
artikel
76 Atherosclerotic obliterative disease Safi, Hazim J.
1998
11 4S1 p. 259A-
1 p.
artikel
77 A003 γ-tocotrienol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats (SHR) Newaz, M.A.
1998
11 4S1 p. 84A-
1 p.
artikel
78 A019 Transforming growth factor-β1 (TGF) modulates mRNA for c-type natriuretic peptide (CNP) in aortic vascular smooth muscle cells (AVSM) Brown, J.
1998
11 4S1 p. 35A-
1 p.
artikel
79 A018 Tumor necrosis factor-alpha attenuates angiotensin II-induced responses in vascular smooth muscle via an eicosanoid-dependent mechanism Askari, B.
1998
11 4S1 p. 35A-
1 p.
artikel
80 Authors, editors, journals, money, disclosure Rennie, Drummond
1998
11 4S1 p. 243A-
1 p.
artikel
81 A032 Vasoactive peptides effect on adenyl cyclase activity and G protein expression in rat vascular smooth muscle cells Boumati, M.
1998
11 4S1 p. 38A-
1 p.
artikel
82 A015 Vasodilator activity of stereo-isomers of S-nitroso-cysteine in rabbit and rat isolated mesenteric arteries Graves, J.E.
1998
11 4S1 p. 87A-
1 p.
artikel
83 B006 Ace inhibitory activity of zofenopril in healthy volunteers: A dose-response study Giusti, A.
1998
11 4S1 p. 41A-
1 p.
artikel
84 B022 Acute blood pressure response to captopril analised by the area under the curve method correlates with renin angiotensin system Matavelli, L.C.
1998
11 4S1 p. 45A-
1 p.
artikel
85 B025 Adenosine activates the vascular renin-angiotensin system in coronary arteries of essential hypertensive patients Virdis, A.
1998
11 4S1 p. 46A-
1 p.
artikel
86 B010 Alteration of sarcoplasmic reticulum gene expression in acute pressure overload-induced hypertrophy in rats Ikeda, S.
1998
11 4S1 p. 142A-
1 p.
artikel
87 B004 Angiotensin I converting enzyme gene polymorphism, lipoprotein (a) levels and family history of stroke Pamies, E.
1998
11 4S1 p. 40A-
1 p.
artikel
88 B001 Angiotensin II — receptor (AT1) blockade reduces ventricular arrhythmias in uncomplicated essential hypertensive patients Crippa, M.
1998
11 4S1 p. 40A-
1 p.
artikel
89 B032 Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independent of blood pressure Jacobi, J.
1998
11 4S1 p. 47A-
1 p.
artikel
90 B005 Angiotensinogen gene polymorphism and lipoprotein profile in essential hypertensive patients Palmero, C.
1998
11 4S1 p. 41A-
1 p.
artikel
91 B027 Assessment of angiotensin II receptor blockade in humans using an in vitro binding assay: Comparison with the in vivo approach Maillard, M.
1998
11 4S1 p. 46A-
1 p.
artikel
92 B012 Calponin gene overexpression in rat aorta is present in the early, but not in the late phase of renovascular hypertension Castoldi, G.
1998
11 4S1 p. 142A-
1 p.
artikel
93 B031 Comparison of the acute renal effect of losartan and captopril in atheromatous renovascular disease Mimran, A.
1998
11 4S1 p. 47A-
1 p.
artikel
94 B013 Comparison of vasoconstrictory effects of angiotensin II and norepinephrine on venous system Malireddi, K.
1998
11 4S1 p. 43A-
1 p.
artikel
95 B008 Decreased QT dispersion in hypertensives after enalaprilat González-Fernández, R.A.
1998
11 4S1 p. 41A-
1 p.
artikel
96 B011 Differences in angiotensinogen mRNA regulation in spontaneously hypertensive rats (SHR) Klett, Christoph P.R.
1998
11 4S1 p. 142A-
1 p.
artikel
97 B026 Differential thromboxane A2 (TxA2) receptor antagonism by angiotensin II AT1 receptor blockers in canine coronary arteries Li, P.
1998
11 4S1 p. 46A-
1 p.
artikel
98 B009 Distinct gene regulation of two angiotensin-generating enzymes by angiotensin II in cardiac fibroblasts Kurooka, A.
1998
11 4S1 p. 142A-
1 p.
artikel
99 B007 Early gene expression for collagenase and collagens I and III in volume-overload cardiac remodeling Dolgilevich, S.M.
1998
11 4S1 p. 141A-
1 p.
artikel
100 B010 Effect of selective AT1 receptor antagonism on arterial compliance in essential hypertension Klemsdal, T.O.
1998
11 4S1 p. 42A-
1 p.
artikel
101 B004 Effects of the selective mineralocorticoid receptor antagonist, eplerenone, in a model of aldosterone-induced hypertension and cardiac fibrosis Frierdich, G.
1998
11 4S1 p. 94A-
1 p.
artikel
102 B002 Eplerenone (SC 66110), A highly selectibe aldosterone antagonist Delyani, John
1998
11 4S1 p. 94A-
1 p.
artikel
103 B006 Fibrosis-related gene expression in the hypertrophied left ventricular tissue of spontaneously hypertensive rats Seccia, T.M.
1998
11 4S1 p. 141A-
1 p.
artikel
104 B002 Heme oxygenase isoforms and endothelial cell function: Implication to blood pressure regulation da Silva, J.-L.
1998
11 4S1 p. 140A-
1 p.
artikel
105 B012 Hyponatremic-hypertensive syndrome in renal ischemia: An under-recognised disorder Agarwal, M.
1998
11 4S1 p. 42A-
1 p.
artikel
106 B003 Is a neuronal pacemaker involved in the regulation of blood pressure rhythm? Expression pattern of mRNA in the suprachiasmatic nuclei in normotensive and transgenic hypertensive rats Hauptfleisch, S.
1998
11 4S1 p. 140A-
1 p.
artikel
107 B014 Ischemic inactivation of G protein-coupled receptor kinase and altered desensitization of canine cardiac β-adrenergic receptors Zhang, M.
1998
11 4S1 p. 143A-
1 p.
artikel
108 B016 Long term safety of losartan in open label trials in patients with mild to moderate essential hypertension Smith, R.D.
1998
11 4S1 p. 43A-
1 p.
artikel
109 B023 Long-term therapy with irbeasartan and hydrochlorothiazide in hypertension Robert, Guthrie
1998
11 4S1 p. 45A-
1 p.
artikel
110 Blood pressure and renal effects of indomethacin during angiotensin II receptor blockade with losartan Olsen, M.E.
1998
11 4S1 p. 10A-
1 p.
artikel
111 Blood pressure and the risk of recurrent vascular disease Neal, B.
1998
11 4S1 p. 25A-
1 p.
artikel
112 Blood pressure: An independent risk factor for cancer Xie, L.D.
1998
11 4S1 p. 20A-
1 p.
artikel
113 Blood pressure control in the anthihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) Cushman, W.C.
1998
11 4S1 p. 17A-
1 p.
artikel
114 B024 Losartan maintains parasympathetic output during nitroglycerin-induced vasodilation Pancera, P.
1998
11 4S1 p. 45A-
1 p.
artikel
115 B015 Microalbuminuria is renin-dependent in hypertensive women Vyssoulis, G.P.
1998
11 4S1 p. 43A-
1 p.
artikel
116 B001 Mineralocorticoid antagonism reduces ANG-II induced renal injury in stroke-prone hypertensive rats Rocha, R.
1998
11 4S1 p. 94A-
1 p.
artikel
117 B013 N-glycosylation of recombinant human angiotensinogen explains the heterogeneity of the protein and is not required for functional activity Gimenez-Roqueplo, A.P.
1998
11 4S1 p. 143A-
1 p.
artikel
118 B021 Nocturnal blood pressure fall correlates positively with plasma renin activity in hypertensives Matavelli, L.C.
1998
11 4S1 p. 45A-
1 p.
artikel
119 B002 Oculohypotensive effect of angiotensin converting enzyme (ACE) inhibitors in acute and chronic models of glaucoma Goyal, R.K.
1998
11 4S1 p. 40A-
1 p.
artikel
120 B003 Ouabain-like immunoreactivity in human plasma Balzan, S.
1998
11 4S1 p. 94A-
1 p.
artikel
121 B017 Polymorphism of angiotensin-converting enzyme in patients with primary glomerulonephritis and hypertension Kuzmanić, D.
1998
11 4S1 p. 44A-
1 p.
artikel
122 B007 QT dispersion and signal average on the prevalence of arrhythmias after regression of hypertrophy in hypertension González-Fernández, R.A.
1998
11 4S1 p. 41A-
1 p.
artikel
123 B011 Renin aldosterone ratio as a discriminator in untreated hypertension Jennings, G.L.
1998
11 4S1 p. 42A-
1 p.
artikel
124 B008 Sarcoplasmic reticulum gene expression in volume-overloaded cardiac hypertrophy induced by an arteriovenous fistula in rats Hashida, H.
1998
11 4S1 p. 141A-
1 p.
artikel
125 B019 Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in the human forearm Lyons, D.
1998
11 4S1 p. 44A-
1 p.
artikel
126 B005 Sodium-dependent regulation of myocardial NA, K-ATPase subunit gene expression Gick, G.
1998
11 4S1 p. 141A-
1 p.
artikel
127 B004 Studies of the mechanisms of vascular smooth muscle cell proliferation induced by homocysteine Tang, J.
1998
11 4S1 p. 140A-
1 p.
artikel
128 B020 Systemic and local ras in NIDDM Price, D.A.
1998
11 4S1 p. 44A-
1 p.
artikel
129 B014 Tasosartan does not affect cardiac output during submaximal exercise in hypertensive patients Rhéaume, C.
1998
11 4S1 p. 43A-
1 p.
artikel
130 B018 The blockade of angiotensin II but not the reduction of systemic blood pressure reduces proteinuria in patients with IgA nephropathy Russo, D.
1998
11 4S1 p. 44A-
1 p.
artikel
131 B001 The cytochrome P450 (CYP) 4A isoforms involved in the synthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) in the rat kidney Wang, M.-H.
1998
11 4S1 p. 140A-
1 p.
artikel
132 B030 The effect of clamping angiotensin II levels during ace-inhibition in healthy volunteers on a high and low salt diet Krekels, M.
1998
11 4S1 p. 47A-
1 p.
artikel
133 B029 The effects of angiotensin II antagonist losartan on urinary albumin excretion in non insulin-dependent diabetes mellitus Ragonesi, P.D.
1998
11 4S1 p. 47A-
1 p.
artikel
134 B028 The importance of the renin angiotensin system in determining blood pressure fall with salt restriction between black and white hypertensive patients He, F.J.
1998
11 4S1 p. 46A-
1 p.
artikel
135 B009 The type 1 angiotensin II receptor gene (AT1R) is not involved in the genetic variability of aldosterone response to AII infusion Giacché, M.
1998
11 4S1 p. 42A-
1 p.
artikel
136 B003 Valsartan protects against angiotensin II induced diastolic dysfunction Shiels, P.
1998
11 4S1 p. 40A-
1 p.
artikel
137 C009 Abnormal intra- and extracellular degradation of cardiac collagen in spontaneously hypertensive rats Seccia, T.M.
1998
11 4S1 p. 90A-
1 p.
artikel
138 C041 Accordance in diagnosis of normo/hypertension among three methods of measuring blood pressure in an elderly population Blanco, F.
1998
11 4S1 p. 58A-
1 p.
artikel
139 C074 Adverse prognostic significance of a blunted circadian rhythm of heart rate in essential hypertension Verdecchia, P.
1998
11 4S1 p. 66A-
1 p.
artikel
140 C005 Age, body size, heart rate, and mean arterial pressure are predictors of arterial hemodynamics in healthy humans Soma, J.
1998
11 4S1 p. 49A-
1 p.
artikel
141 C039 A generalised pressure transfer function between central and upper limb arterial pressure Segers, P.
1998
11 4S1 p. 57A-
1 p.
artikel
142 C021 Alerting reaction is not related to early signs of cardiovascular damage Marotta, T.
1998
11 4S1 p. 53A-
1 p.
artikel
143 C054 Alert reaction to ambulatory blood pressure monitoring (ABPM) López-Contreras, J.
1998
11 4S1 p. 61A-
1 p.
artikel
144 C018 Ambulatory arterial pressure monitoring in hypertensive and normal children Machado, C.E.
1998
11 4S1 p. 52A-
1 p.
artikel
145 C028 Ambulatory blood pressure measurement in isolated systolic hypertension of the elderly Zottola, C.
1998
11 4S1 p. 54A-
1 p.
artikel
146 C055 Ambulatory blood pressure monitoring in the evaluation of resistant hypertension López-Contreras, J.
1998
11 4S1 p. 61A-
1 p.
artikel
147 C017 Ambulatory blood pressure monitoring: Randomized study of hypertensive patients with left ventricular hypertrophy Machado, C.E.
1998
11 4S1 p. 52A-
1 p.
artikel
148 Cancer risk in hypertensive patients treated with calcium channel blockers McInnes, G.T.
1998
11 4S1 p. 9A-
1 p.
artikel
149 C008 Antiproliferative actions of high density lipoprotein in aortic smooth muscle cell (SMC) cultures Locher, R.
1998
11 4S1 p. 145A-
1 p.
artikel
150 Cardiac function and dysfunction: Molecular and cellular mechanisms Kranias, E.G.
1998
11 4S1 p. 235A-
1 p.
artikel
151 Cardiorenal and sympathetic effects of leptin in spontaneously hypertensive lean and obese koletsky rats Correia, M.L.G.
1998
11 4S1 p. 22A-
1 p.
artikel
152 Cardiovascular risk reduction dietary intervention trial: Rationale and design McCarron, D.A.
1998
11 4S1 p. 237A-
1 p.
artikel
153 Case study of the New Zealand experience Jackson, Rodney
1998
11 4S1 p. 242A-
1 p.
artikel
154 C033 A simple way to mark guidelines on blood pressure cuffs Meert, R.L.
1998
11 4S1 p. 56A-
1 p.
artikel
155 C058 Assessment of the antihypertensive effect of a drug: Conventional blood pressure measurement techniques vs. ambulatory blood pressure monitoring Calvo-Vargas, C.G.
1998
11 4S1 p. 62A-
1 p.
artikel
156 C010 Autonomic nervous function in female mild essential hypertension Murakami, E.
1998
11 4S1 p. 50A-
1 p.
artikel
157 C026 Blood pressure changes during exercise in patients with “white collar” and “real hypertension” Kanonidis, I.E.
1998
11 4S1 p. 54A-
1 p.
artikel
158 C075 Blood pressure fall depends on salt-sensitivity and on salt overload intensity in essential hypertensives Santello, J.L.
1998
11 4S1 p. 66A-
1 p.
artikel
159 C009 Blood pressure variability and organ damage in hypertensive patients Calvo, C.
1998
11 4S1 p. 50A-
1 p.
artikel
160 C062 Blunted blood pressure circadian rhythm is already evident in hypertensives older than fifties Fazzari, L.
1998
11 4S1 p. 63A-
1 p.
artikel
161 C071 Can self-monitoring of blood pressure at home replace ambulatory monitoring in the assessment of the white coat effect? Stergiou, G.S.
1998
11 4S1 p. 65A-
1 p.
artikel
162 C081 Cardiac dysrhythmias, left ventricular function, atrial activation and volumes in non-dippers hypertensive subjects with left ventricular hypertrophy Villatico Campbell, S.
1998
11 4S1 p. 68A-
1 p.
artikel
163 C008 Cholesterol (CHOL) exacerbates hypertension in puromycin (P) induced focal glomerulosclerosis (FGS) Ghosh, S.S.
1998
11 4S1 p. 89A-
1 p.
artikel
164 C085 Cognitive evaluation of general nurses' blood pressure reading techniques in the new civil hospital of guadalajara Parra-Carrillo, J.Z.
1998
11 4S1 p. 260A-
1 p.
artikel
165 C013 Comparison of multiple definitions of circadian time periods to analyze ambulatory blood pressure monitoring (ABPM) data Eissa, M.
1998
11 4S1 p. 51A-
1 p.
artikel
166 C015 Comparison of repeated office blood pressure measurements versus 24hr. Ambulatory blood pressure monitoring Punzi, H.A.
1998
11 4S1 p. 51A-
1 p.
artikel
167 C019 Confiability in the arterial blood pressure measurements by digital wrist blood pressure monitor Machado, C.E.
1998
11 4S1 p. 52A-
1 p.
artikel
168 C002 Control of blood pressure during the development of obesity-induced hypertension Antic, V.
1998
11 4S1 p. 88A-
1 p.
artikel
169 C080 Control of cyclosporine induced hypertension Freitas, J.
1998
11 4S1 p. 67A-
1 p.
artikel
170 C027 Correlation between acute myocardial ischaemic episodes and variations of blood pressure in hypertensive patients during cardiac catheterization Psirropoulos, D.
1998
11 4S1 p. 54A-
1 p.
artikel
171 C065 Data on the ambulatory blood pressure monitoring (ABPM) in the development of left ventricular hypertrophy(LVH) in the incipient systemic blood pressure hypertension(SH) Costa, L.S.
1998
11 4S1 p. 64A-
1 p.
artikel
172 C004 Decreased cutaneous capillary density in the spontaneously hypertensive rat Rendell, M.S.
1998
11 4S1 p. 88A-
1 p.
artikel
173 C030 Determination of 24-hour blood pressure control in a treated population who appear to be controlled based upon office blood pressure measurements Wilson, M.D.
1998
11 4S1 p. 55A-
1 p.
artikel
174 C006 Development of renal damage in hypertensive fawn-hooded rats is not affected by gonadectomy Provoost, A.P.
1998
11 4S1 p. 89A-
1 p.
artikel
175 C013 Different effects of calcium blockers on large arteries fluid filtration and albumin permeability in hypertensive rats Lacolley, P.
1998
11 4S1 p. 91A-
1 p.
artikel
176 C020 Differential effects of pressurization on mechanical properties in small arteries from uninephrectomized and doca-salt rats Intengan, H.D.
1998
11 4S1 p. 92A-
1 p.
artikel
177 C001 Differential gene expression of the platelete-derived growth factor α-receptor in vascular smooth muscle cells of genetically hypertensive rats Takata, Y.
1998
11 4S1 p. 144A-
1 p.
artikel
178 C009 Differential renal expression of TGF-β isoforms in the SHR/N-corpulent rat with diabetic nephropathy Velasquez, M.T.
1998
11 4S1 p. 146A-
1 p.
artikel
179 C084 Does control of clinic blood pressure reflect adequate blood pressure control during exercise in treated hypertensive subjects? Lim, P.O.
1998
11 4S1 p. 68A-
1 p.
artikel
180 C083 Does white coat effect contribute to blood pressure variability? Lim, P.O.
1998
11 4S1 p. 68A-
1 p.
artikel
181 C014 Doxazosin-stimulated apoposis in left ventricules of spontaneously hypertensive rats Rodriguez-Feo, J.A.
1998
11 4S1 p. 91A-
1 p.
artikel
182 C011 Effect of angiotensin II and transforming growth factor-β on collagen secretion in cardiac fibroblasts Petrov, V.
1998
11 4S1 p. 146A-
1 p.
artikel
183 C015 Effect of high salt intake and isolation on digitalis-like factors in fisher 344xNB rats Federova, O.V.
1998
11 4S1 p. 91A-
1 p.
artikel
184 C043 Effect of hypertension on the brachial artery pressure-area curve Drzewiecki, G.
1998
11 4S1 p. 58A-
1 p.
artikel
185 C006 Effect of mibefradil on the proliferation of human peripheral blood mononuclear cells Lijnen, P.
1998
11 4S1 p. 145A-
1 p.
artikel
186 C078 Effect of race on blood pressure (BP) change in experimental stress Yamasaki, F.
1998
11 4S1 p. 67A-
1 p.
artikel
187 C068 Effect of salt ancohol restriction, and pharmacological treatment on blood pressure variability assessed by “smoothness index” De la Sierra, A.
1998
11 4S1 p. 64A-
1 p.
artikel
188 C012 Effects of calcium antagonist miberfradil on large arteries in spontaneously hypertensive rats Koffi, I.
1998
11 4S1 p. 90A-
1 p.
artikel
189 C021 Endothelin-1, endothelin-3 and endothelin converting-enzyme-1 mRNA in renal tissue of the prague hypertensive rat Vogel, V.
1998
11 4S1 p. 93A-
1 p.
artikel
190 C018 Enhanced pressor response to phenylephrine in Mg++ deficient Na+ loaded rats Miletich, D.J.
1998
11 4S1 p. 92A-
1 p.
artikel
191 C059 Estimation of circadian blood pressure profile in essential hypertension using exercise blood pressure response Yin, D.F.
1998
11 4S1 p. 62A-
1 p.
artikel
192 C073 Evaluation of the technique for taking blood pressure by health care workers in an University Hospital Rocha, J.C.
1998
11 4S1 p. 66A-
1 p.
artikel
193 C051 Evaluation of three devices for self-measurement of blood pressure according to the British hypertension society protocol: The omron M1 MX2 Y M4 Artigao, L.Miguel
1998
11 4S1 p. 60A-
1 p.
artikel
194 C053 Excess of body fluid may induce morning rise in blood pressure profile Sone, M.
1998
11 4S1 p. 61A-
1 p.
artikel
195 C016 Expense/benefit ratio and reliability of digital wrist blood pressure monitor in dialysis units Machado, C.E.
1998
11 4S1 p. 51A-
1 p.
artikel
196 C019 Experimental study of calcium antagonist on vasculoprotection: Effect of azelnidipine: On hypertensive vascular injury in dahl salt sensitive rat Yamakado, M.
1998
11 4S1 p. 92A-
1 p.
artikel
197 C061 Feasibility of 24-H cerebral blood flow velocity monitoring and continuous finger arterial blood pressure in healthy subjects Diamant, M.
1998
11 4S1 p. 63A-
1 p.
artikel
198 C024 Gender differences in hemodynamic response to dynamic exercise Gollamudi, M.
1998
11 4S1 p. 53A-
1 p.
artikel
199 C025 Hemodynamic response pattern to isometric exercise is different between genders Sung, B.H.
1998
11 4S1 p. 54A-
1 p.
artikel
200 C007 High potassium (K) diets reduce mortality and brain injury after bilateral carotid ligation Tobian, L.
1998
11 4S1 p. 89A-
1 p.
artikel
201 C042 High sodium intake and its relationship with blood pressure in normotensive adolescent offspring of hypertensives Rabinovich, Laura
1998
11 4S1 p. 58A-
1 p.
artikel
202 Chronic AT1 blockade prevents cardiac apoptosis in adult SHR via inhibition of bax protein Ravassa, S.
1998
11 4S1 p. 7A-
1 p.
artikel
203 Chronotherapy is less likely than homeostatic therapy to induce low sleep systolic blood pressure in patients with hypertension White, W.B.
1998
11 4S1 p. 17A-
1 p.
artikel
204 C017 Increased Ser16- and THR17-phospholamban phosphorylation in hearts of hypertensive rats Bartel, S.
1998
11 4S1 p. 92A-
1 p.
artikel
205 C004 Influence of doctor's gender on alerting reaction in the elderly C., Del Arco-Galán
1998
11 4S1 p. 48A-
1 p.
artikel
206 C060 Influence of left ventricular mass on aortic root size in uncomplicated hypertension Galderisi, M.
1998
11 4S1 p. 62A-
1 p.
artikel
207 C001 Inhibition of 20-HETE lowers blood pressure in rats with angiotensin II (ANG II) induced hypertension following no inhibition Brand-Schieber, E.
1998
11 4S1 p. 88A-
1 p.
artikel
208 C012 Inhibition of Vascular smooth muscle cell proliferation by two calcium antagonists Deslandes-Le Flohic, F.
1998
11 4S1 p. 146A-
1 p.
artikel
209 C013 Intracellular free calcium acts as a signaling in attachment and migration induced by thrombospondin in smooth muscle cells Xie, L.D.
1998
11 4S1 p. 147A-
1 p.
artikel
210 C004 Inverse relationship between potassium intake and vascular lesion formation in coronary arteries of rabbits Ma, G.
1998
11 4S1 p. 144A-
1 p.
artikel
211 Circadian variation of blood pressure and its impact on the management of the elderly hypertensive patients Elliott, W.J.
1998
11 4S1 p. 254A-
1 p.
artikel
212 Circadian variation of blood pressure in the assessment of pharmacologic therapy for hypertension — the CESNA and TIMED trials White, William B.
1998
11 4S1 p. 251A-
1 p.
artikel
213 C082 Is there any association between ambulatory pulse pressure and left ventricular mass in essencial hypertensive patients? Amado, P.
1998
11 4S1 p. 68A-
1 p.
artikel
214 C037 Lean subjects show no correlation between nocturnal blood pressure and target organ damage Matavelli, L.C.
1998
11 4S1 p. 57A-
1 p.
artikel
215 Clinical relevance of blood pressure variability Parati, Gianfranco
1998
11 4S1 p. 248A-
1 p.
artikel
216 C007 Low density lipoprotein oxidation and vitamins E and C in dipper and nondipper hypertensive patients Pierdomenico, S.D.
1998
11 4S1 p. 49A-
1 p.
artikel
217 C003 Lysophosphatidic acid activates protein kinase C isoforms α, β, ϵ and Σ in vascular smooth muscle cells Seewald, S.
1998
11 4S1 p. 144A-
1 p.
artikel
218 C046 Menopause and blood pressure variability Andronico, G.
1998
11 4S1 p. 59A-
1 p.
artikel
219 C047 Mid-pregnancy blood pressure decrease in normal and complicated pregnancies Livi, R.
1998
11 4S1 p. 59A-
1 p.
artikel
220 C069 Misclassification of the subjects with white coat hypertension Palatini, P.
1998
11 4S1 p. 65A-
1 p.
artikel
221 C044 “Napping” is frequent in hypertensive subjects undergoing ambulatory blood pressure monitoring Mansoor, G.A.
1998
11 4S1 p. 58A-
1 p.
artikel
222 C003 Need of reference values from ambulatory blood pressure monitoring for the diagnosis of white coat hypertension Crippa, G.
1998
11 4S1 p. 48A-
1 p.
artikel
223 C007 Neointimal cellular composition following angioplasty in atherosclerotic non human primates. Potential role of myofibroblasts Fukuhara, M.
1998
11 4S1 p. 145A-
1 p.
artikel
224 C048 New aspects of post-prandial hypotension in the elderly hypertension Campanini, M.
1998
11 4S1 p. 59A-
1 p.
artikel
225 C066 Nocturnal blood pressure decline as a predictor for cardiac and renal damage in hypertension Rodriguez, S.A.
1998
11 4S1 p. 64A-
1 p.
artikel
226 C001 Nondippers with essential hypertension have greater sleep activity than dippers Mansoor, G.A.
1998
11 4S1 p. 48A-
1 p.
artikel
227 Cocaine stimulates central sympathetic outflow in humans: A novel mechanism of cocaine-induced acute hypertension Vongpatanasin, W.
1998
11 4S1 p. 14A-
1 p.
artikel
228 C076 Office vs home blood pressure monitoring and left ventricular mass index Gomes, M.A.M.
1998
11 4S1 p. 66A-
1 p.
artikel
229 Combination drug therapy in the elderly Prisant, L.Michael
1998
11 4S1 p. 255A-
1 p.
artikel
230 Comparative effects of the AT1 — Receptor blocker exp 3174 and the ace-inhibitor captopril on canine renal glomerular hemodynamics Heller, J.
1998
11 4S1 p. 12A-
1 p.
artikel
231 Comparison of hypertension (HTN) control in an HMO population to NHANES III Hunkeler, E.M.
1998
11 4S1 p. 16A-
1 p.
artikel
232 Comparison of the effects of tasosartan and losartan on ambulatory blood pressure in patients with essential hypertension Neutel, J.
1998
11 4S1 p. 9A-
1 p.
artikel
233 Complicated hypertension patients-diabetes and insulin resistance Hsueh, Willa A.
1998
11 4S1 p. 247A-
1 p.
artikel
234 Concentration-effect relationships for antihypertensive drugs Meredith, Peter A.
1998
11 4S1 p. 248A-
1 p.
artikel
235 Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetics and the renally impaired Elliott, W.J.
1998
11 4S1 p. 8A-
1 p.
artikel
236 C020 Physicians' opinions and behaviour concerning the home measurement of blood pressure Diaz, M.E.
1998
11 4S1 p. 52A-
1 p.
artikel
237 C079 Post prandial hypotension in essential hypertensive patients: Evaluation by ambulatory blood pressure monitoring Uemura, K.
1998
11 4S1 p. 67A-
1 p.
artikel
238 C067 Prediction of long-term changes of blood pressure and left ventricular mass in borderline hypertension Iida, S.
1998
11 4S1 p. 64A-
1 p.
artikel
239 C063 Prevalence and determinants of microalbuminuria in untreated mild hypertensive subjects. Hospitalet study Torres, G.
1998
11 4S1 p. 63A-
1 p.
artikel
240 C014 Proximal thoracic aorta dimensions in hypertensive patients: Lack of correlation between ABPM data and 2D echocardiography Gianrossi, R.
1998
11 4S1 p. 51A-
1 p.
artikel
241 C035 Pulse pressure and left ventricular mass in “non-dippers” and “peakers” Ramos, F.
1998
11 4S1 p. 56A-
1 p.
artikel
242 C010 Quantificationof the renal nitric oxide production in hypertensive rats during sepsis Rochette, L.
1998
11 4S1 p. 90A-
1 p.
artikel
243 C008 Refractary hypertension in elderly hypertensive patients. Importance of ambulatory blood pressure monitoring Amado, P.
1998
11 4S1 p. 49A-
1 p.
artikel
244 C034 Regression to the mean in ambulatory blood pressure measurements, its magnitude and consequences: Is only one ABPM enough? Ramos, F.
1998
11 4S1 p. 56A-
1 p.
artikel
245 C003 Regulation of blood pressure during long-term ouabain infusion in intact and uninephrectomized rats Wang, J.L.
1998
11 4S1 p. 88A-
1 p.
artikel
246 C031 Relaxation methods for blood pressure (BP) overswinging; Need for timing Lee, M.S.
1998
11 4S1 p. 55A-
1 p.
artikel
247 C002 Reliability of casual blood pressure measurement in normotensive and hypertensive subjects Guida, G.F.
1998
11 4S1 p. 48A-
1 p.
artikel
248 C070 Reproducibility of the circadian variability by 24-H ABPM in essential hypertension(EH) Sobrino, J.
1998
11 4S1 p. 65A-
1 p.
artikel
249 C011 Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic tsukuba hypertensive mice Kai, T.
1998
11 4S1 p. 90A-
1 p.
artikel
250 Cross-classification of blood pressure stages and risk groups in the framingham heart study Levy, D.
1998
11 4S1 p. 21A-
1 p.
artikel
251 Cross-talk between ACE and bradykinin B2 receptor Erdös, Ervin G.
1998
11 4S1 p. 239A-
1 p.
artikel
252 Crude physical mapping of quantitative trait loci for blood pressure on rat chromosome 2 Deng, A.Y.
1998
11 4S1 p. 6A-
1 p.
artikel
253 C050 Salt loading increases nocturnal blood pressure fall in salt resistant black normotensive and hypertensive subjects Damasceno, A.
1998
11 4S1 p. 60A-
1 p.
artikel
254 C016 Salt overload before and during pregnancy: Effects on the dams and offspring Silva, A.A.
1998
11 4S1 p. 91A-
1 p.
artikel
255 C029 Seasonal variations in clinic, home and ambulatory blood pressure Sega, R.
1998
11 4S1 p. 55A-
1 p.
artikel
256 C057 Self-measurement blood pressure readings using a “loaned equipment” model Calvo-Vargas, C.G.
1998
11 4S1 p. 62A-
1 p.
artikel
257 C077 “Siesta” interferes on daytime ambulatory blood pressure monitoring Gomes, M.A.M.
1998
11 4S1 p. 67A-
1 p.
artikel
258 C040 Similarity of simultaneously-recorded and derived ascending aortic pressure wave contour and amplitude under control conditions and with vasodilator therapy Soderstrom, S.
1998
11 4S1 p. 57A-
1 p.
artikel
259 C012 Talking effect and white coat phenomenon in elderly hypertensive patients Le Pailleur, C.
1998
11 4S1 p. 50A-
1 p.
artikel
260 C045 The correlation and difference between nurse-measured blood pressure and ambulatory blood pressure Liu, Ju-Chi
1998
11 4S1 p. 59A-
1 p.
artikel
261 C064 The correlation between the ambulatory blood pressure monitoring (ABPM) data with the presence of left ventricular hypertrophy (LVH) in the systemic arterial hypertension (SH) Costa, L.S.
1998
11 4S1 p. 63A-
1 p.
artikel
262 C011 The increase of the fibrinolytic-coagulation system in patients with non-dipper essential hypertension Kitagawa, I.
1998
11 4S1 p. 50A-
1 p.
artikel
263 C010 The serum of patients treated with fluvastatin induces apoptosis in human monocitoid cells Buemi, M.
1998
11 4S1 p. 146A-
1 p.
artikel
264 C038 The vascular overload index: A more sensitive parameter for central hemodynamics in essential hypertension Segers, P.
1998
11 4S1 p. 57A-
1 p.
artikel
265 C049 The white-coat response in ambulatory normotensive and hypertensive subjects can be identified by analysing the initial two ambulatory measurements Gama, G.
1998
11 4S1 p. 60A-
1 p.
artikel
266 C002 Thyrotropin receptor (TSHR) in cultured human coronary artery smooth muscle cells (CASMC) Sellitti, D.F.
1998
11 4S1 p. 144A-
1 p.
artikel
267 C005 Transforming growth factor-β1 (TGF-β1) and collagen type III (COL-III) in hyperoxaluric (Hox) rats treated with losartan (L) Toblli, J.E.
1998
11 4S1 p. 145A-
1 p.
artikel
268 C022 Underlying mechanism of gender difference in systolic blood pressure Vavilala, C.
1998
11 4S1 p. 53A-
1 p.
artikel
269 C036 Usefulness of wavelet-based real-time analysis of blood pressure and heart rate variability Matsumoto, K.
1998
11 4S1 p. 56A-
1 p.
artikel
270 C052 Validity of self-reported blood pressure measurements in ambulatory hypertension patients Johnson, K.A.
1998
11 4S1 p. 60A-
1 p.
artikel
271 C056 Variability of ambulatory blood pressure in normal pregnancy López-Contreras, J.
1998
11 4S1 p. 61A-
1 p.
artikel
272 C005 Variation of cardiac structure and left ventricular systolic function in patients with essential hypertension Xi-feng, Wang
1998
11 4S1 p. 89A-
1 p.
artikel
273 C072 Which is the best strategy to diagnose hypertension: Based on home, ambulatory or clinic blood pressure measurements? Stergiou, G.S.
1998
11 4S1 p. 65A-
1 p.
artikel
274 C006 White-coat responder hypertension Pierdomenico, S.D.
1998
11 4S1 p. 49A-
1 p.
artikel
275 C032 Why do current health practitioners not measure blood pressure according to AHA guidelines? Grim, C.M.
1998
11 4S1 p. 55A-
1 p.
artikel
276 C023 Young normotensive men maintain higher systolic blood pressure during awake and sleep periods Gill, S.S.
1998
11 4S1 p. 53A-
1 p.
artikel
277 Cytoprotective properties of a long-acting calcium channel blocker: New mechanisms of action Mason, R.Preston
1998
11 4S1 p. 254A-
1 p.
artikel
278 D025 Ambulatory blood pressure (ABP) and echocardiographic left ventricular dimensions in dippers, non-dippers and normotensives Ziakas, G.N.
1998
11 4S1 p. 75A-
1 p.
artikel
279 D053 Ambulatory blood pressure monitoring for the evaluation of the time-effect profile of amlodipine vs perindopril Zannad, F.
1998
11 4S1 p. 82A-
1 p.
artikel
280 D030 Ambulatory blood pressure monitoring in patients with concentric remodeling or concentric hypertrophy Piñeiro, D.J.
1998
11 4S1 p. 76A-
1 p.
artikel
281 D041 Analysis of regional diastolic changes due to cardiac hypertrophy by doppler tissue imaging Galderisi, M.
1998
11 4S1 p. 79A-
1 p.
artikel
282 D052 Angiotensin converting enzyme inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients Hausberg, M.
1998
11 4S1 p. 81A-
1 p.
artikel
283 D009 Antihypertensive effects of tasosartan and hydrochlorothiazide alone and in combination in ambulatory hypertensives Lacourcière, Y.
1998
11 4S1 p. 71A-
1 p.
artikel
284 D056 Association of metabolic factors with the early cerebrovascular manifestations in mild hepertensive males Britov, A.N.
1998
11 4S1 p. 82A-
1 p.
artikel
285 D021 Baseline characteristics of the first 6482 patients enrolled in the convince study Black, H.R.
1998
11 4S1 p. 74A-
1 p.
artikel
286 D042 Candesartan cilexetil (CC): A meta-analysis of time-to-effect relationship Sever, P.
1998
11 4S1 p. 79A-
1 p.
artikel
287 D006 Changes of muscarinic M2-cholinoceptors during the development of hypertension in spontaneously hypertensive rats Chan, Paul
1998
11 4S1 p. 149A-
1 p.
artikel
288 D023 Comparison of eprosartan and enalapril on incidence of cough in hypertensive patients with history of ace inhibitor-induced cough Oparil, S.
1998
11 4S1 p. 74A-
1 p.
artikel
289 D035 CS-866 (angiotensin-II receptor antagonist): A double-blind study using ambulatory blood pressure monitoring in hypertensive patients Masonson, H.N.
1998
11 4S1 p. 77A-
1 p.
artikel
290 D003 Dehydroepiandrosterone-sulphate and carotid intimal-media thickness in pre and post-menopausal women Bernini, G.P.
1998
11 4S1 p. 95A-
1 p.
artikel
291 D001 Development of essential hypertension and modification in baroreceptor reflex effect on sinus node Voita, D.
1998
11 4S1 p. 148A-
1 p.
artikel
292 D048 Does surgical menopause increases the salt sensitivity in women? Aranda, P.
1998
11 4S1 p. 80A-
1 p.
artikel
293 D027 Does the presence of either concurrent hypertension or non-insulin-dependent diabetes mellitus affect the efficacy and safety of atorvastatin in patients with hyperlipidemia? Black, D.M.
1998
11 4S1 p. 75A-
1 p.
artikel
294 D031 Early cardiac structural and functional alterations in IDDM Carugo, S.
1998
11 4S1 p. 76A-
1 p.
artikel
295 D036 Effect of alcohol on postprandial blood pressure Suter, P.M.
1998
11 4S1 p. 77A-
1 p.
artikel
296 D015 Effect of long term eprosartan versus enalapril antihypertensive therapy on LV mass and coronary flow reserve in stage I–II hypertension Diamond, J.A.
1998
11 4S1 p. 72A-
1 p.
artikel
297 D049 Effect of sodium intake on renal excretion of fluid He, F.J.
1998
11 4S1 p. 81A-
1 p.
artikel
298 D004 Effect of tibolone on clinic and ambulatory blood pressure (ABP) Sánchez-Chaparro, M.A.
1998
11 4S1 p. 95A-
1 p.
artikel
299 D026 Effects of early ACE-inhibition in hypertensive patients with AMI Borghi, C.
1998
11 4S1 p. 75A-
1 p.
artikel
300 D010 Effects of nicotine gum on cross-sectional area of coronary artery stenoses Nitenberg, A.
1998
11 4S1 p. 71A-
1 p.
artikel
301 D002 Effects of the chronotherapeutic delivery of verapamil on circadian blood pressure in African-American patients with hypertension White, W.B.
1998
11 4S1 p. 69A-
1 p.
artikel
302 D057 Efficacy of eprosartan in elderly patients with hypertension Argenziano, L.
1998
11 4S1 p. 83A-
1 p.
artikel
303 D043 Efficacy of eprosartan in patients with essential hypertension: A 26-week comparison study of eprosartan versus enalapril Gavras, H.
1998
11 4S1 p. 79A-
1 p.
artikel
304 Deletion polymorphism of ace gene affects insulin resistance in never treated hypertensive patients Perticone, F.
1998
11 4S1 p. 12A-
1 p.
artikel
305 D033 Encapsulation of commercially available losartan (COZAAR®) does not influence its bioavailability Nyman, L.
1998
11 4S1 p. 77A-
1 p.
artikel
306 D001 Estrogen replacement therapy don't change blood pressure but decrease pulse wave velocity in normotensive posmenopausal women Maldonado, J.
1998
11 4S1 p. 95A-
1 p.
artikel
307 Determining probability of hypertension from ambulatory blood pressure (ABP) monitoring using the individual's vs. the pooled standard deviation Moore, C.R.
1998
11 4S1 p. 23A-
1 p.
artikel
308 D058 Evaluation of regional diastolic function in hypertensive patients using doppler myocardial imaging Deljanin Ilić, M.Ž.
1998
11 4S1 p. 83A-
1 p.
artikel
309 D044 Factors influencing treatment compliance in hypertensive patients: Results of a large scale study using electronic pill boxes Valsse, B.
1998
11 4S1 p. 79A-
1 p.
artikel
310 D022 Hypertension as cause of atrial fibrillation Zarifis, J.
1998
11 4S1 p. 74A-
1 p.
artikel
311 D046 Hypertensive heart patients — 10 years of follow up Yurenev, A.P.
1998
11 4S1 p. 80A-
1 p.
artikel
312 D045 Hypertensive patients quality of life: Results from the hyppos project Zaninelli, A.
1998
11 4S1 p. 80A-
1 p.
artikel
313 Diabetic neuropathy and sexual dysfunction Garber, Alan J.
1998
11 4S1 p. 259A-
1 p.
artikel
314 Diagnosis and management of the patient with erectile dysfunction Montague, Drogo K.
1998
11 4S1 p. 259A-
1 p.
artikel
315 Diet and blood pressure: Established risk factors, emerging nutrients and prevention of the high blood pressure epidemic Elliott, Paul
1998
11 4S1 p. 237A-
1 p.
artikel
316 Dietary approaches to stop hypertension (DASH): Results and implications Vogt, Thomas M.
1998
11 4S1 p. 237A-
1 p.
artikel
317 D055 Increased demands in recruitment effort from the pilot to the full-scale phase in the African American study of kidney disease and hypertension (AASK) Phillips, R.A.
1998
11 4S1 p. 82A-
1 p.
artikel
318 D003 Inhibition of calcineurin causes renal afferent activation in rats: A novel mechanism of cyclosporine-induced hypertension Zhang, W.
1998
11 4S1 p. 148A-
1 p.
artikel
319 D018 Is excessive hypertension in acute myocardial infarction (AMI) associated with a worse outcome Jonas, M.
1998
11 4S1 p. 73A-
1 p.
artikel
320 D003 Is white coat hypertension genetic- ally innocent? Park, J.B.
1998
11 4S1 p. 69A-
1 p.
artikel
321 D029 Left ventricular geometry in pregnancy induced hypertension Vázquez Blanco, M.
1998
11 4S1 p. 76A-
1 p.
artikel
322 D004 Long acting calcium channel blockers in hypertension. Amlodipine vs nifedipine GITS comparative study Motero, J.
1998
11 4S1 p. 69A-
1 p.
artikel
323 D034 Long-term effects of candesartan cilexetil on the systemic and renal haemodynamics in moderately hypertensive patients Fridman, Katarina
1998
11 4S1 p. 77A-
1 p.
artikel
324 D019 Long term efficacy and tolerability of diovan® in elderly hypertensive patients compared with lisinopril Meilenbrock, S.
1998
11 4S1 p. 73A-
1 p.
artikel
325 D024 Long term safety and efficacy of valsartan Hall, J.
1998
11 4S1 p. 74A-
1 p.
artikel
326 D020 Lower incidence of cough with eprosartan compared with enalapril: A primary analysis in unselected hypertensive patients Elliott, W.
1998
11 4S1 p. 73A-
1 p.
artikel
327 D038 Marital cohesion and ambulatory blood pressure in early hypertension Baker, Brian
1998
11 4S1 p. 78A-
1 p.
artikel
328 D016 Methods for determining salt-sensitivity in adolescent outpatient populations Wilson, D.K.
1998
11 4S1 p. 72A-
1 p.
artikel
329 D017 Multi-center collaborative trial of angiotensin II receptor antagonism on morbidity, mortality and renal function in hypertensive type II diabetic patients with nephropathy Porush, J.G.
1998
11 4S1 p. 73A-
1 p.
artikel
330 DO ace inhibitors protect against cancer? McInnes, G.T.
1998
11 4S1 p. 16A-
1 p.
artikel
331 Do ace inhibitors reduce mortality in hypertensive patients? McInnes, G.T.
1998
11 4S1 p. 20A-
1 p.
artikel
332 Does treatment-mediated increase in uric acid reduce the cardioprotective effect of diuretics in hypertensive patients? Alderman, M.H.
1998
11 4S1 p. 16A-
1 p.
artikel
333 D007 Once-daily zofenopril provides 24-hour ambulatory blood pressure control in hypertensive patients aged under 65 years Malacco, E.
1998
11 4S1 p. 70A-
1 p.
artikel
334 Do nonsteroidal anti-inflammatory drugs really affect blood pressure? Girerd, X.
1998
11 4S1 p. 19A-
1 p.
artikel
335 D004 Pharmacological caracterization of the cardiovascular effects of zolpidem Castro, J.L.
1998
11 4S1 p. 148A-
1 p.
artikel
336 D001 Rapid progression to ESRD in cocaine-associated hypertensive subjects Sigue, G.
1998
11 4S1 p. 69A-
1 p.
artikel
337 D005 Reduced cardiopulmonary receptor sensitivity in normotensive black immigrants Modesti, P.A.
1998
11 4S1 p. 149A-
1 p.
artikel
338 D050 Reduction of left ventricular mass by manidipine hydrochloride Hase, M.I.
1998
11 4S1 p. 81A-
1 p.
artikel
339 D011 Relationship between flow-mediated vasodilatation and distensibility of the brachial artery in essential hypertension Barenbrock, M.
1998
11 4S1 p. 71A-
1 p.
artikel
340 Drug safety: Lessons learned Furberg, Curt D.
1998
11 4S1 p. 235A-
1 p.
artikel
341 D013 Safety and the frequency of second and third degree atrioventricular block during adenosine stress testing in patients with uncontrolled hypertension Tabriz, A.N.
1998
11 4S1 p. 72A-
1 p.
artikel
342 D014 Safety of adenosine stress radionuclide myocardial perfusion study in patients with symptomatic carotid artery stenosis Tabriz, A.N.
1998
11 4S1 p. 72A-
1 p.
artikel
343 D039 Safety of eprosartan in elderly patients with hypertension Harland, D.
1998
11 4S1 p. 78A-
1 p.
artikel
344 D051 Study by ABPM type of untreated essential hypertension cases Hase, M.O.
1998
11 4S1 p. 81A-
1 p.
artikel
345 D047 Study on cognition and prognosis in the elderly (SCOPE). Design and objectives Hansson, L.
1998
11 4S1 p. 80A-
1 p.
artikel
346 D032 Study population and treatment titration in the International Nifedipine GITS Study Intervention as a goal in hypertension treatment (INSIGHT) Brown, M.J.
1998
11 4S1 p. 76A-
1 p.
artikel
347 D040 Subgroup analysis of black hypertensive patients treated with eprosartan or enalapril: Results of a 26-week study Levine, B.
1998
11 4S1 p. 78A-
1 p.
artikel
348 D005 Symptom reduction in a study of two calcium antagonists in essential hypertension Mosler, A.L.
1998
11 4S1 p. 70A-
1 p.
artikel
349 D002 The association of estrogens and progestins as replacement therapy don't change blood pressure but decrease pulse wave velocity in normotensive posmenopausal women Maldonado, J.
1998
11 4S1 p. 95A-
1 p.
artikel
350 D008 The C.A.D.HYP. study: Coronary artery disease in hypertension Palmiero, P.
1998
11 4S1 p. 70A-
1 p.
artikel
351 D006 The combination of valsartan and hydrochlorothiazide is effective and well tolerated in essential hypertension Black, H.
1998
11 4S1 p. 70A-
1 p.
artikel
352 D028 The dose efficacy of atorvastatin compared with four other statins in the management of hyperlipidemic patients — the curves study Kafonek, S.
1998
11 4S1 p. 75A-
1 p.
artikel
353 D037 The safety of adenosine pharmacologic stress testing in patients with end-stage renal disease Geloo, N.A.
1998
11 4S1 p. 78A-
1 p.
artikel
354 D002 Vagal cardiac activity in essential hypertension the effects of metoprolol and ramipril Vesalainen, R.K.
1998
11 4S1 p. 148A-
1 p.
artikel
355 D012 Valsartan antihypertensive longterm use evaluation (the value study) Julius, S.
1998
11 4S1 p. 71A-
1 p.
artikel
356 D054 Visit (VAd) and medication adherence (MAd) in the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): Effect of age and other factors Nwachuku, C.E.
1998
11 4S1 p. 82A-
1 p.
artikel
357 E015 Absence of first dose response in elderly hypertensive patients treated with perindopril Rubio, A.F.
1998
11 4S1 p. 99A-
1 p.
artikel
358 E093 A comparison of cough in hypertensive patients receiving telmisartan, lisinopril, or placebo Lacourcière, Y.
1998
11 4S1 p. 119A-
1 p.
artikel
359 E080 A comparison of telmisartan with lisinopril in patients with mild to moderate hypertension Neutel, J.
1998
11 4S1 p. 115A-
1 p.
artikel
360 E141 A comparison of the blood pressure profile of telmisartan and losartan at 18–24 hours post-dosing as measured by ambulatory blood pressure monitoring (ABPM) Mallion, J.M.
1998
11 4S1 p. 262A-
1 p.
artikel
361 E109 Acute effects of nifedipine on left ventricular diastolic function. Relationships with plasma catecholamines changes Cerasola, G.
1998
11 4S1 p. 123A-
1 p.
artikel
362 E041 Ambulatory blood pressure monitoring and the decision about withdrawing from antihypertensive monotherapy Nedogoda, S.V.
1998
11 4S1 p. 106A-
1 p.
artikel
363 E115 Amlodipine versus amlodipine plus doxazosin in low doses for treating type 2 diabetics with essential HBP and microalbuminuria Aranda, P.
1998
11 4S1 p. 124A-
1 p.
artikel
364 E084 Analysis of the grade of compliance in hypertension results of 1 population study Masso, Javier
1998
11 4S1 p. 116A-
1 p.
artikel
365 E017 A new method for quantitative assessment of edema during chronic treatment with calcium entry blockers Andresdottir, M.B.
1998
11 4S1 p. 100A-
1 p.
artikel
366 E036 Angiotensin converting enzyme inhibitor reduced total vascular tone and left ventricular hypertrophy in patients with essential hypertension Mori, H.
1998
11 4S1 p. 104A-
1 p.
artikel
367 E040 Antihypertension and remolding hypertrophied ventricular by amlodipine xing, Hua
1998
11 4S1 p. 105A-
1 p.
artikel
368 E004 Antihypertensive effect of three different diuretics in black patients with mild to moderate hypertension Radevski, I.V.
1998
11 4S1 p. 96A-
1 p.
artikel
369 E120 Antihypertensive therapy with losartan and fosinopril: Efficacy in left ventricular hypertrophy regression Villatico Campbell, S.
1998
11 4S1 p. 125A-
1 p.
artikel
370 E111 Antihypertensive treatment improves the ankle/arm blood pressure index in patients with essential hypertension Manolis, A.J.
1998
11 4S1 p. 123A-
1 p.
artikel
371 E099 A randomized, double-blind, parallel study of the safety and antihypertensive efficacy of losartan vs amlodipine in patients with mild to moderate hypertension and impaired renal function Fernández-Andrade, C.
1998
11 4S1 p. 120A-
1 p.
artikel
372 Early myocardial involvement in hypertensive patients with and without angina Zoneraich, S.
1998
11 4S1 p. 7A-
1 p.
artikel
373 E087 Assessment of sexual dysfunction with bisoprolol/hydrochlorothiazide, bisoprolol, hydrochlorothiazide, enalapril and amlodipine Prisant, L.M.
1998
11 4S1 p. 117A-
1 p.
artikel
374 E009 Blood pressure and insulin metabolism are influenced by the dietary salt consumption Furukawa, L.N.S.
1998
11 4S1 p. 152A-
1 p.
artikel
375 E137 Blood pressure control and quality of life in postmenopausal woman: A randomized clinical trial with different ACE inhibitors Nedogoda, S.V.
1998
11 4S1 p. 261A-
1 p.
artikel
376 E031 Calcium channel blockers (CCBS) are used selectively for high-risk hypertensive patients Huse, D.M.
1998
11 4S1 p. 103A-
1 p.
artikel
377 E101 Candesartan cilexetil enhances blood pressure reduction in severe (stage 3, JNC-VI) hypertensive patients inadequately controlled with HCTZ Oparil, S.
1998
11 4S1 p. 121A-
1 p.
artikel
378 E106 Candesartan cilexetil is not associated with cough in patients with enalapril-induced cough Tanser, P.
1998
11 4S1 p. 122A-
1 p.
artikel
379 E104 Cardiovascular effects of mibefradil in obstructive sleep apnea Heitman, J.
1998
11 4S1 p. 121A-
1 p.
artikel
380 Echocardiography is important to determine end-organ changes and guide management in hypertension. The pro debate position Phillips, Robert A.
1998
11 4S1 p. 256A-
1 p.
artikel
381 E056 Combination of candesartan cilexetil/hydrochlorothiazide 8/12.5 mg has a similar antihypertensive effect and is better tolerated than lisinopril/hydrochlorothiazide 10/12.5 mg McInnes, G.T.
1998
11 4S1 p. 109A-
1 p.
artikel
382 E083 Comparative efficacy of a low-salt diet, nifedipine-gits, hydrochlorothiazide and their combinations in salt-sensitive black hypertensive patients assessed by 24-H BP monitoring Damasceno, A.
1998
11 4S1 p. 116A-
1 p.
artikel
383 E014 Comparative study of a low dose of isosorbide spray (IS) vs sublingual nifedipine (SN) in the treatment of hypertensive emergencies (HE) Rubio, A.F.
1998
11 4S1 p. 99A-
1 p.
artikel
384 E006 Comparative study of doxazosin and hydrochlorothiazide when added to nonresponders to ace inhibitor enalapril therapy Marti, J.C.
1998
11 4S1 p. 97A-
1 p.
artikel
385 E020 Comparision of diltiazem and nifedipine on heart rate variability in patients with uncomplicated hypertension Miyajima, E.
1998
11 4S1 p. 100A-
1 p.
artikel
386 E057 Comparison of efficacy and safety of mibefradil, enalapril and amlodipine in mild to moderate hypertension Kahn, J.C.
1998
11 4S1 p. 110A-
1 p.
artikel
387 E136 Comparison of long-term metabolic effects of ACE inhibitors and calcium channel blockers in patients with essential hypertension Campo, C.
1998
11 4S1 p. 261A-
1 p.
artikel
388 E126 Comparison of the antihypertensive efficacy of ace-inhibitors treatment combined with a diuretic or a calcium antagonist by ambulatory blood pressure monitoring Omboni, S.
1998
11 4S1 p. 127A-
1 p.
artikel
389 E034 Comparison of the effects of tasosartan and losartan on the blood pressure response to exercise in patients with essential hypertension Chrysant, S.
1998
11 4S1 p. 104A-
1 p.
artikel
390 E112 Comparison of the efficacy and safety of three dihydropyridine calcium channel antagonists in black hypertensive adults Hall, W.D.
1998
11 4S1 p. 123A-
1 p.
artikel
391 E079 Comparison of the impact of missed doses of tasosartan and losartan on control of ambulatory blood pressure in essential hypertension Gradman, A.
1998
11 4S1 p. 115A-
1 p.
artikel
392 E028 Correction on calcium and magnesium homeostasis disturbances during pharmacotherapy of hypertensive patients Kolomiets, V.V.
1998
11 4S1 p. 102A-
1 p.
artikel
393 E002 Correlation of insulin sensitivity measures derived from IVGTT and euglycemic clamp in hypertensive subjects Waib, P.H.
1998
11 4S1 p. 150A-
1 p.
artikel
394 E027 Differential antihypertensive therapy of physically active patients with essential hypertension Predel, H.G.
1998
11 4S1 p. 102A-
1 p.
artikel
395 E038 Differential effects of propranolol and labetalol on nighttime blood pressure Johnson, J.A.
1998
11 4S1 p. 105A-
1 p.
artikel
396 E011 Dissociation between albuminuria and insulinemia in hypertensive and atherosclerotic men Pedrinelli, R.
1998
11 4S1 p. 152A-
1 p.
artikel
397 E118 Divergent effects of β-blocker on self-assessed and objectively scored activities of daily living (ADL) Kamiyama, T.
1998
11 4S1 p. 125A-
1 p.
artikel
398 E054 Does hypertension cause proteinuria? Reddy, M.S.
1998
11 4S1 p. 109A-
1 p.
artikel
399 E095 Does the clinic blood pressure measurement overestimate blood pressure control in treated hypertensive patients? Cuspidi, C.
1998
11 4S1 p. 119A-
1 p.
artikel
400 E062 Dose response and pharmacokinetics of telmisartan, a new angiostensin II receptor blocker Neutel, J.M.
1998
11 4S1 p. 111A-
1 p.
artikel
401 E051 Drug interaction studies with eprosartan, A novel angiotensin II receptor antagonist Ilson, B.
1998
11 4S1 p. 108A-
1 p.
artikel
402 E135 Edema as a symptom in a study of lacidipine versus nifedipine gits in essential hypertension Alcocer, L.
1998
11 4S1 p. 261A-
1 p.
artikel
403 E107 Effect of amlodipine protecting the transplanted kidney on hypertension after kidney transplantation Shude, Tang
1998
11 4S1 p. 122A-
1 p.
artikel
404 E010 Effect of antihypertensive drugs on foetal growth in hypertensive pregnant women Lydakis, C.
1998
11 4S1 p. 98A-
1 p.
artikel
405 E074 Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients Malamani, G.D.
1998
11 4S1 p. 114A-
1 p.
artikel
406 E070 Effect of lisinopril-losartan combination on insulin resistance in overweight hypertensive patients Zoppi, A.
1998
11 4S1 p. 113A-
1 p.
artikel
407 E048 Effect of losartan on ambulatory blood pressure (ABP) and insulin resistance (IR) in non-insulin dependent diabetes (NIDDM) Lazarus, J.H.
1998
11 4S1 p. 107A-
1 p.
artikel
408 E001 Effect of nifedipine on insulin sensitivity and hyperinsulinaemia in indian patients. A correlation with experimental studies Mehta, A.A.
1998
11 4S1 p. 150A-
1 p.
artikel
409 E008 Effect of γ-tocotrienol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR) Newaz, M.A.
1998
11 4S1 p. 97A-
1 p.
artikel
410 E066 Effect of trandolapril and losartan on plasma PAI-I and fibrinogen in hypertensive post-menopausal women Mugellini, A.
1998
11 4S1 p. 112A-
1 p.
artikel
411 E073 Effect of transdermal clonidine on microalbuminuria in diabetic hypertensive patients Fogari, R.
1998
11 4S1 p. 114A-
1 p.
artikel
412 E078 Effect of verapamil on myocardial ischemia in hypertensive patients Palma, J.L.
1998
11 4S1 p. 115A-
1 p.
artikel
413 E071 Effects of amlodipine and indomethacin on cough induced by benazepril: A double blind, randomized cross-over study Fogari, R.
1998
11 4S1 p. 113A-
1 p.
artikel
414 E122 Effects of changes of plasma drug concentrations on blood presses, intracellular free Ca2+ concentrations, concentrations of plasma angiotensin II in essential hypertensive patient with oral single dose of amlodipine therapy Bei-Ying, Wu
1998
11 4S1 p. 126A-
1 p.
artikel
415 E013 Effects of combination of doxazosin and troglitazone of insulin sensitivity and plasma norepinephrine in spontaneously hypertensive rats Takahashi, A.
1998
11 4S1 p. 153A-
1 p.
artikel
416 E075 Effects of different dihydropyridine calcium antagonists on pretibial subcutaneous tissue pressure in hypertensive patients Fogari, R.
1998
11 4S1 p. 114A-
1 p.
artikel
417 E067 Effects of felodipine addition to ramipril on albuminuria in diabetic hypertensive patients with impaired renal function Corradi, L.
1998
11 4S1 p. 112A-
1 p.
artikel
418 E072 Effects of fosinopril addition to amlodipine on microalbuminura in elderly hypertensive patients with diabetes Fogari, R.
1998
11 4S1 p. 113A-
1 p.
artikel
419 E076 Effects of losartan addition to lisinopril in hypertension: A 24-hour ABPM study Fogari, R.
1998
11 4S1 p. 114A-
1 p.
artikel
420 E139 Effects of losartan on 24-hour blood pressure and its variability in mild to moderate hypertension Biagini, M.
1998
11 4S1 p. 262A-
1 p.
artikel
421 E117 Effects of nebivolol and atenolol on regional and systemic hemodynamics at rest and during exercise in hypertensives subjects Marceau, M.
1998
11 4S1 p. 125A-
1 p.
artikel
422 E026 Effects of trandolapril and nifedipine-gits on whole body and skeletal muscle insulin sensitivity in overweight hypertensives Galletti, F.
1998
11 4S1 p. 102A-
1 p.
artikel
423 E055 Effects of ultra low-dose combination of bisoprolol/hydrochlorothiazide systolic hypertension in the elderly Benetos, A.
1998
11 4S1 p. 109A-
1 p.
artikel
424 E019 Efficacy and safety of the fixed combination verapamil SR/trandolapril 180/2 mg in hypertensive patients insufficiently pretreated with trandolapril 2 mg monotherapy Beevers, D.G.
1998
11 4S1 p. 100A-
1 p.
artikel
425 E049 Efficacy and tolerability of lercanidipine vs. captopril in patients with mild to moderate hypertension in a double-blind controlled study Barbagallo, M.
1998
11 4S1 p. 108A-
1 p.
artikel
426 E102 Enhanced dihydropyridine-induced increase in sympathetic activity is secondary to increases in minimum nerve activity Calhoun, D.A.
1998
11 4S1 p. 121A-
1 p.
artikel
427 E138 Evaluation of 24-hour antihypertensive effects of two formulations of once daily verapamil: A randomized blinded crossover study Westfall, G.R.
1998
11 4S1 p. 261A-
1 p.
artikel
428 E113 Evaluation of the arterial and the antihypertensive effects of the combination of trandolapril and verapamil versus each monocomponent Topouchian, J.
1998
11 4S1 p. 124A-
1 p.
artikel
429 E004 Evidence against insulin-mediated vasodilation in human forearm Høieggen, A.
1998
11 4S1 p. 150A-
1 p.
artikel
430 E039 Extended therapeutic control in essential hypertension: Comparison of the impact of missed doses of tasosartan and losartan Lacourciere, Y.
1998
11 4S1 p. 105A-
1 p.
artikel
431 E108 Felodipine as monotherapy and associated to enalapril for essential hypertension Navarro, J.F.
1998
11 4S1 p. 122A-
1 p.
artikel
432 Effect of a unique chimeric peptide synthesized from brain natriuretic peptide and C-type natriuretic peptide on afferent arteriole Wei, C.
1998
11 4S1 p. 24A-
1 p.
artikel
433 Effect of irbesartan on structure and mechanical properties of small arteries from the spontaneously hypertensive rat Intengan, H.D.
1998
11 4S1 p. 18A-
1 p.
artikel
434 Effects of ARB-ACEI combination therapy on morbidity and mortality in heart failure Cohn, J.N.
1998
11 4S1 p. 257A-
1 p.
artikel
435 Effects of dihydropyridine calcium antagonist therapy on 24 hour baroreflex sensitivity in hypertension Vaile, J.C.
1998
11 4S1 p. 10A-
1 p.
artikel
436 Effects of parathyroid hypertensive factor on L-type calcium channels and voltage gated potassium channels in vascular smooth muscle Benishiri, C.G.
1998
11 4S1 p. 14A-
1 p.
artikel
437 Effects of prolonged ace inhibition on the vascular consequences of aging in SHR Maeso, R.
1998
11 4S1 p. 12A-
1 p.
artikel
438 Efficacy of AT1 receptor blockade in hypertension Moore, Michael A.
1998
11 4S1 p. 252A-
1 p.
artikel
439 E090 Fixed-dose combination versus monotherapy in hypertension: A meta-analysis evaluation Hilleman, D.E.
1998
11 4S1 p. 118A-
1 p.
artikel
440 E008 Genetically hypertensive rats of the Lyon strain (LH) are not insulin-resistant Boulanger, M.
1998
11 4S1 p. 151A-
1 p.
artikel
441 E014 Glucose utilization and response to insulin in vascular smooth muscle cells (VSMC) of WKY and SHR Raviv, Y.
1998
11 4S1 p. 153A-
1 p.
artikel
442 E021 Guanabenz inhibits sympathetic nerve activity and regresses left ventricular hypertrophy Miyajima, E.
1998
11 4S1 p. 101A-
1 p.
artikel
443 E082 Has captopril a direct pro-apoptotic effect? Buemi, M.
1998
11 4S1 p. 116A-
1 p.
artikel
444 E081 Heart rate response in the early morning hours (6am–12n) to chronotherapy and homeostatictherapy in patients with hypertension or in patients with myocardial ischemia Glasser, S.P.
1998
11 4S1 p. 116A-
1 p.
artikel
445 E003 Hyperinsulinemia modifies the glucose response to mental stress independent of blood flow Høieggen, A.
1998
11 4S1 p. 150A-
1 p.
artikel
446 E006 Hypertension and insulin resistance correlate with intracellular ionized calcium of polymorphonuclear leukocytes Kristal, B.
1998
11 4S1 p. 151A-
1 p.
artikel
447 E114 Hypocalciuric and antihypertensive effects of losartan versus hydrochlorothiazide in the hypertensive postmenopausal women Aranda, P.
1998
11 4S1 p. 124A-
1 p.
artikel
448 E085 Hypotensive and nephroprotective effects of losartan in rats with high fructose diet Seculin, P.
1998
11 4S1 p. 117A-
1 p.
artikel
449 E069 Inhibition by (-)-Cicletanine of the calcium signal elicited by vasopressin in the A10 vascular smooth muscle cell line Alda, O.
1998
11 4S1 p. 113A-
1 p.
artikel
450 E007 Insulin attenuates angiotensin II-induced venoconstriction in man Akkus, N.I.
1998
11 4S1 p. 151A-
1 p.
artikel
451 E005 Insulin resistance and cardiac hypertrophy are present in middle-aged female spontaneously hypertensive rats (SHR), but are attenuated by ovariectomy Swislocki, A.
1998
11 4S1 p. 151A-
1 p.
artikel
452 E010 Insulin sensitivity in pre-eclampsia Tedde, R.
1998
11 4S1 p. 152A-
1 p.
artikel
453 E053 Integral treatment of hypertension in menopausal women Garcia, F.
1998
11 4S1 p. 109A-
1 p.
artikel
454 E016 Lacidipine and cerebral perfusion in uncomplicated essential hypertensives with mild to moderate carotid artery stenosis Semplicini, A.
1998
11 4S1 p. 99A-
1 p.
artikel
455 E007 Lacidipine and nifedipine gits as fixed-dose monopharmacotherapies in essential hypertension over sixteen weeks: Main results of the lastlhy Reyes, A.J.
1998
11 4S1 p. 97A-
1 p.
artikel
456 E129 Late decrease in body weight during therapy of essential hypertension with calcium antagonists Alcocer, L.
1998
11 4S1 p. 128A-
1 p.
artikel
457 E119 Left ventricular function stabilization and its mass regretion during long-term treatment with capoten in patients with hypertension Kipshidze, N.
1998
11 4S1 p. 125A-
1 p.
artikel
458 Elevated diastolic pressure — The first sign predicting nephropathy in type 1 diabetes and a possible factor in retinopathy Paulsen, E.P.
1998
11 4S1 p. 8A-
1 p.
artikel
459 Elevated free fatty acids (FFA) Levels impair endothelium dependent vasodilation (EDV) Baron, Alain D.
1998
11 4S1 p. 241A-
1 p.
artikel
460 E089 Local reflex regulation of skin blood flow and leg volume during calcium channel blockade in essential hypertensives Pelosi, E.
1998
11 4S1 p. 118A-
1 p.
artikel
461 E059 Long term blood pressure control with losartan alone or in combination with hydrochlorothiazide or other antihypertensive drugs in patients with mild to moderate essential hypertension Aurup, P.
1998
11 4S1 p. 110A-
1 p.
artikel
462 E018 Long-term effects of fosinopril on target organ damage in hypertensive patients Paletas, K.
1998
11 4S1 p. 100A-
1 p.
artikel
463 E123 Long-term effects of moxonidine on arterial pressure and on metabolic parameters in patients with essential hypertension Lefkos, N.
1998
11 4S1 p. 126A-
1 p.
artikel
464 E012 Long term follow up of acute renal failure due to angiotensin converting enzyme inhibitors Wynckel, A.
1998
11 4S1 p. 98A-
1 p.
artikel
465 E024 Long-term safety and efficacy of irbesartan (up to 300 mg) in hypertension Littlejohn III, T.
1998
11 4S1 p. 101A-
1 p.
artikel
466 E134 Long-term treatment with either ace inhibitors or calcium channel blockers in patients with essential hypertension do not modify renal function Campo, C.
1998
11 4S1 p. 129A-
1 p.
artikel
467 E033 Losartan effectiveness and tolerability (LET) study Moore, M.A.
1998
11 4S1 p. 104A-
1 p.
artikel
468 E133 Losartan® improves diastolic function of hypertensive patients Ayoub, J.C.A.
1998
11 4S1 p. 129A-
1 p.
artikel
469 E125 Losartan induces LVMI reduction, better if combined to ace-inhibitors? One year follow-up Bossini, A.
1998
11 4S1 p. 127A-
1 p.
artikel
470 E029 Losartan (LOS) and uric acid (UA) in chronic renal failure and end-stage renal disease (ESRD) Sica, D.
1998
11 4S1 p. 103A-
1 p.
artikel
471 E064 Magnetic resonance imaging can detect the volumetric change of left atrium associated with antihypertensive therapy Mineoi, K.
1998
11 4S1 p. 111A-
1 p.
artikel
472 E013 Management of hypertensive emergencies in the elderly with isosorbide spray Rubio, A.F.
1998
11 4S1 p. 99A-
1 p.
artikel
473 E098 Mibefradil, a selective T-Type CA2 channel blocker, compared to nifedipine gits and enalapril in the treatment of hypertension Calhoun, D.
1998
11 4S1 p. 120A-
1 p.
artikel
474 E097 Mibefradil, a selective T-type CA2 channel blocker, compares favorably with the ace inhibitor enalapril in the treatment of hypertension Villa, G.
1998
11 4S1 p. 120A-
1 p.
artikel
475 E058 Mibefradil, new T-channel calcium blocker, is more efficient to decrease the diastolic diurnal blood pressure than hydrochlorothiazide or enalapril in elderly hypertensive Forette, B.
1998
11 4S1 p. 110A-
1 p.
artikel
476 E012 Moderate dietary salt restriction aggravates vascular insulin resistance Schmidt, N.D.
1998
11 4S1 p. 152A-
1 p.
artikel
477 E110 More effective blood pressure control with felodipine-metoprolol combination than with amlodipine. 24-hour ambulatory blood pressure monitoring Zannad, E.
1998
11 4S1 p. 123A-
1 p.
artikel
478 E132 National hypertension treatment in the VA for 1995 and 1996: Medication patterns and costs implications Siegel, D.
1998
11 4S1 p. 128A-
1 p.
artikel
479 Endothelial dysfunction in human hypertension and atherosclerosis Creager, Mark A.
1998
11 4S1 p. 238A-
1 p.
artikel
480 Endothelin Barton, M.
1998
11 4S1 p. 239A-
1 p.
artikel
481 E092 Nephroprotective and antihypertrophic effect of irbesartan at low-dose in experimental type II diabetes Villa, E.
1998
11 4S1 p. 118A-
1 p.
artikel
482 E127 Neurohumoral effects of losartin in long-term administration in subjects with hypertension Koval, S.N.
1998
11 4S1 p. 127A-
1 p.
artikel
483 E044 Nifedipine-Sl and isradipine trough to peak ratios at 24-hour ambulatory monitoring Petrov, V.I.
1998
11 4S1 p. 106A-
1 p.
artikel
484 E003 Nisoldipine is superior to enalapril in severe hypertension — Double blind randomised study Radevski, I.V.
1998
11 4S1 p. 96A-
1 p.
artikel
485 E061 Once daily telmisartan as compared to enalapril in the treatment of hypertension Smith, D.H.G.
1998
11 4S1 p. 111A-
1 p.
artikel
486 E050 Overview of the clinical pharmacology eprosartan, a novel angiotensin II receptor antagonist Ilson, B.
1998
11 4S1 p. 108A-
1 p.
artikel
487 E002 Persistence of antihypertensive effect — A comparison of enalapril (E), felodipine ER (F) and nifedipine-GITS (N) Myers, M.G.
1998
11 4S1 p. 96A-
1 p.
artikel
488 E128 Pharmacokinetics of identical doses of diltiazem delivered via different long-acting delivery systems in hypertensive patients Smith, D.H.G.
1998
11 4S1 p. 127A-
1 p.
artikel
489 E130 Pharmacotherapy of essential hypertension with two calcium antagonists: Blood pressure responses over sixteen weeks analyzed by the montevideo mathematical model (MMM) Alcocer, L.
1998
11 4S1 p. 128A-
1 p.
artikel
490 E035 Preliminary pharmacokinetics of CI-992 in cynomolgus monkey and human plasma Barksdale, C.M.
1998
11 4S1 p. 104A-
1 p.
artikel
491 E052 Primary resistant hypertension characteristics of patients with essential hypertension B., Jelaković
1998
11 4S1 p. 108A-
1 p.
artikel
492 E100 Rapid adjustment of antihypertensive drugs produces a durable improvement in blood pressure Canzanello, V.J.
1998
11 4S1 p. 120A-
1 p.
artikel
493 E105 Realization of anti-angina and anti-ischemic ACE-inhibitor cilazapril effects in hypertensive patients with coronary artery disease Pavlyukova, E.N.
1998
11 4S1 p. 122A-
1 p.
artikel
494 E005 Reduction in 24 hour systolic blood pressure ⩽135 MMHG is associated with greater degree of left ventricular mass regression in black patients with severe hypertension Radevski, I.V.
1998
11 4S1 p. 97A-
1 p.
artikel
495 E086 Regression of renal damage induced by HFD in rats by means of antihypertensive treatment Cosenzi, A.
1998
11 4S1 p. 117A-
1 p.
artikel
496 E088 Renoprotective effects of a new calcium antagonist, efonidipine, in SHR with glomerular injury Takabatake, T.
1998
11 4S1 p. 117A-
1 p.
artikel
497 E025 Safety and efficacy of irbesartan in patients with hypertension and renal insufficiency Cooper, M.
1998
11 4S1 p. 102A-
1 p.
artikel
498 E131 Semipersonalized evaluation of well being and physical activity in a study of two calcium antagonists in essential hypertension Mosler, A.L.
1998
11 4S1 p. 128A-
1 p.
artikel
499 E045 Sibutramine induces weight loss but not BP increase in obese hypertensive patients taking beta-blockers Liebowitz, M.T.
1998
11 4S1 p. 107A-
1 p.
artikel
500 E047 Simulatenous measurement of pharmacodynamics and pharmacokinetics of S-nitrosocaptopril in hypertensive rats Jia, L.
1998
11 4S1 p. 107A-
1 p.
artikel
501 E037 S-nitrosocaptopril crystal: Physicochemical characterization and antihypertensive effects Jia, L.
1998
11 4S1 p. 105A-
1 p.
artikel
502 E140 Step-down therapy in celiprolol treated hypertensive patients Iwata, T.
1998
11 4S1 p. 262A-
1 p.
artikel
503 Estradiol lowers nocturnal blood pressure in postmenopausal women Seely, E.W.
1998
11 4S1 p. 15A-
1 p.
artikel
504 E068 Study on the effects of earthworm fibrinolytic enzyme on platelet aggregation and absorption after oral administration Li, X.D.
1998
11 4S1 p. 112A-
1 p.
artikel
505 E009 Systemic arterial hemodynamics in ambulatory hypertension during treatment with atenolol and captopril Soma, J.
1998
11 4S1 p. 98A-
1 p.
artikel
506 E032 The accupril titration intervention management interval management evaluation [ATIME] trial Flack, J.M.
1998
11 4S1 p. 103A-
1 p.
artikel
507 E094 The addition of candesartan cilexetil to HCTZ enhances blood pressure reduction in black patients with severe (stage 3, JNC-VI) hypertension Ripley, E.
1998
11 4S1 p. 119A-
1 p.
artikel
508 E046 The angiotensin-II receptor blocker candesartan cilexetil provides 24-hour blood pressure control with once-a-day administration in mild-to-moderate hypertension Zuchske, C.A.
1998
11 4S1 p. 107A-
1 p.
artikel
509 E142 The angiotensin-II receptor blocker candesartan cilexetil provides 24-hour blood pressure control with once-a-day administration in mild-to-moderate hypertension Zuschke, C.A.
1998
11 4S1 p. 262A-
1 p.
artikel
510 E030 The antihypertensive and neurohumoral effects of losartan (LOS) in end-stage renal disease (ESRD) peritoneal dialysis (PD) patients Gehr, T.
1998
11 4S1 p. 103A-
1 p.
artikel
511 E022 The AT1 receptor antagonist irbesartan blocks thromboxane A2-induced vasoconstriction in canine coronary arteries Li, P.
1998
11 4S1 p. 101A-
1 p.
artikel
512 E011 The combination of valsartan and benazepril in patients with chronic renal disease Ruilope, Luis M.
1998
11 4S1 p. 98A-
1 p.
artikel
513 E065 The cronology of development of the losartan antihypertensive efficacy: A 24-h ABPM study Preti, P.
1998
11 4S1 p. 112A-
1 p.
artikel
514 E043 The effect of different classes of antihypertensive drugs on the morning surge in blood pressure Petrov, V.I.
1998
11 4S1 p. 106A-
1 p.
artikel
515 E103 The effect of imidapril on circadian blood pressure profile and heart rate variability in essential hypertension Ijiri, H.
1998
11 4S1 p. 121A-
1 p.
artikel
516 E096 The effect of losartan on left ventricular mass in hypertensive patients. Double blind comparison study with verapamil Lonati, L.
1998
11 4S1 p. 119A-
1 p.
artikel
517 E124 The effects of amlodipine on urinary microalbumine excretion in hypertensive patients with salt sensitivity: A comparison with enalapril Liu, Z.O.
1998
11 4S1 p. 126A-
1 p.
artikel
518 E116 The efficacy and safety of telmisartan compared to atenolol and placebo in patients with hypertension Elliott, H.L.
1998
11 4S1 p. 124A-
1 p.
artikel
519 E063 The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension Neutel, J.M.
1998
11 4S1 p. 111A-
1 p.
artikel
520 E023 The pharmacokinetics of irbesartan are not altered in special populations Marino, M.
1998
11 4S1 p. 101A-
1 p.
artikel
521 E121 The relationship between changes of plasma drug concentration, intracellular calcium concentration and ambulatory blood pressure monitoring with amlodipine monodose therapy Dong-Yang, Yang
1998
11 4S1 p. 126A-
1 p.
artikel
522 Ethnic differences in 24-hour blood pressure control in treated hypertensives Hyman, D.J.
1998
11 4S1 p. 10A-
1 p.
artikel
523 E001 Treatment of essential hypertension with hydrochlorothiazide combined with ACE-I or K+channel-I Crippa, M.
1998
11 4S1 p. 96A-
1 p.
artikel
524 E091 Treatment of hypertension after renal transplantation under cyclosporine immunosuppression comparative study on the long-term effect of verapamil, enalapril and doxazosine Martínez-Castelao, A.
1998
11 4S1 p. 118A-
1 p.
artikel
525 E077 Treatment with enalapril to lithiasis and hypertensive patients cause a decrease in urinary citrate excretion Arteaga, J.
1998
11 4S1 p. 115A-
1 p.
artikel
526 E042 Trough to peak ratios at 24-hour ambulatory monitoring during captopril, lisnopril, enalapril and ramipril treatment Nedogoda, S.V.
1998
11 4S1 p. 106A-
1 p.
artikel
527 Evaluation of the tolerability of losartan, compared to captopril, nifedipine or atenolol Calvo, C.
1998
11 4S1 p. 17A-
1 p.
artikel
528 E060 Vasorelaxant effect of (+) and (-) enantiomers of cicletanine in isolated human mesenteric arteries Dorofeeva, N.A.
1998
11 4S1 p. 110A-
1 p.
artikel
529 Evidence that C-site of angiotensin converting enzyme is responsible for bradykinin metabolism in human tissues Bevilacqua, M.
1998
11 4S1 p. 13A-
1 p.
artikel
530 Experimental diabetic nephropathy: Role of the renin-angiotensin system Cooper, M.E.
1998
11 4S1 p. 236A-
1 p.
artikel
531 Expression pattern of soluble guanylyl cyclase in Dahl salt-sensitive and salt-resistant rats Ahmed, Atif
1998
11 4S1 p. 24A-
1 p.
artikel
532 F006 Ambulatory blood pressure (A.B.P.) levels and coronary obstruction degree in coronaropatics Restori, G.
1998
11 4S1 p. 131A-
1 p.
artikel
533 F001 Blood pressure variability in repaired aortic coarctation Marinho-da-Silva, A.J.
1998
11 4S1 p. 130A-
1 p.
artikel
534 F011 Cigarette and coronary artery disease (C.A.D.) Restori, G.
1998
11 4S1 p. 132A-
1 p.
artikel
535 F002 Control of blood pressures among hypertensives by physician directed nurse protocol Carr, A.A.
1998
11 4S1 p. 130A-
1 p.
artikel
536 F009 Coronary obstruction and cigarettes Restori, G.
1998
11 4S1 p. 132A-
1 p.
artikel
537 F007 Differences in ionized calcium distribution between blood plasma and cell depending on hypertension grade Bezrodnava, L.
1998
11 4S1 p. 155A-
1 p.
artikel
538 F004 Drug treatment of arterial hypertension in population Burkadze, N.
1998
11 4S1 p. 130A-
1 p.
artikel
539 F004 Effect of nitric oxide donors and synthase agonist peptides on endothelial cell uptake of L-arginine Ogonowski, A.A.
1998
11 4S1 p. 154A-
1 p.
artikel
540 F003 Elevated red blood cell sodium-lithium countertransport and low lymphocyte cytosolic calcium are markers of insulin resistance in essential hypertension Rivera, Alicia
1998
11 4S1 p. 154A-
1 p.
artikel
541 F008 Erythrocyte NaKCl cotransporter NKCCl isoform in Dahl salt-sensitive rats Alvarez-Guerra, M.
1998
11 4S1 p. 155A-
1 p.
artikel
542 F011 Further evidence for the presence of endogenous substances with digitalis-like biological activity in essential hypertensive patients Paci, A.
1998
11 4S1 p. 156A-
1 p.
artikel
543 F010 Impaired receptor but not G-protein regulation of Na+/H+ exchanger-3 (NHE-3) in proximal tubule membranes of spontaneously hypertensive rats (SHR) Xu, J.
1998
11 4S1 p. 156A-
1 p.
artikel
544 F001 Mapkinase and regulation of sodium-proton exchanger in human red blood cell (RBC) Sartori, M.
1998
11 4S1 p. 154A-
1 p.
artikel
545 F005 Membrane magnesium in preeclampsia Kisters, K.
1998
11 4S1 p. 155A-
1 p.
artikel
546 F012 Obesity is under-diagnosed in hypertensive patients in the primary care setting Alam, H.
1998
11 4S1 p. 132A-
1 p.
artikel
547 F013 Ouabain-like factors in human urine: Identification of a NaK-ATPase inhibitor as vanadium-diascorbate adduct Kramer, H.J.
1998
11 4S1 p. 157A-
1 p.
artikel
548 F014 Peculiarities of tissue potassium balance and myoelectric signal dynamics during handgrip at essential hypertension Vitols, A.
1998
11 4S1 p. 157A-
1 p.
artikel
549 F002 Platelet NA+/H+ exchanger activity is increased in fructose FED borderline hypertensive rats Masai, M.
1998
11 4S1 p. 154A-
1 p.
artikel
550 F009 Regulation of Na+/H+ exchanger-3 (NHE-3) by G-protein subunits in renal brush border membranes Albrecht, F.E.
1998
11 4S1 p. 156A-
1 p.
artikel
551 F006 Regulation of the plasma membrane calcium ATPase by low density lipoproteins in vascular smooth muscle cells and pericytes Skinner, S.
1998
11 4S1 p. 155A-
1 p.
artikel
552 F008 Relationship between silent cerebrovascular damage and blood pressure variation in patients with coronary artery disease Hoshide, S.
1998
11 4S1 p. 131A-
1 p.
artikel
553 Frequency of a polymorphism of the alpha subunit of the epithelial NA channel in essential hypertension Persu, A.
1998
11 4S1 p. 6A-
1 p.
artikel
554 F005 Smoke, ambulatory blood pressure (A.B.P.) and coronary obstruction degree Restori, G.
1998
11 4S1 p. 131A-
1 p.
artikel
555 F010 Smoke worsen haemorrheological parameters in subjects with coronary artery disease (C.A.D.) Restori, G.
1998
11 4S1 p. 132A-
1 p.
artikel
556 F007 The relationship between insulin resistance syndrome and silent lacunar infarction in elderly hypertensive patients Nakagawa, Y.
1998
11 4S1 p. 131A-
1 p.
artikel
557 F015 The significance of intracellular potassium and plasma ionized calcium in hypertensive patients with ECG changes of hypokalemia Delgado-Leon, A.J.
1998
11 4S1 p. 157A-
1 p.
artikel
558 F012 Triglycerides not insulin resistance principally determine sodium-lithium countertransport activity in patients with familial hyperchylomicronaemia Wierzbicki, A.S.
1998
11 4S1 p. 156A-
1 p.
artikel
559 Functional significance of angiotensin receptors Siragy, Helmy M.
1998
11 4S1 p. 251A-
1 p.
artikel
560 F003 Waist to hip ratio affects vascular response to acetylcholine in normotensive subjects Perticone, F.
1998
11 4S1 p. 130A-
1 p.
artikel
561 F013 1-Year treatment with orlistat produces clinically significant weight loss Davidson, M.H.
1998
11 4S1 p. 133A-
1 p.
artikel
562 G008 Ambulatory blood pressure patterns vary in elders living in different residential settings Harper, G.J.
1998
11 4S1 p. 135A-
1 p.
artikel
563 G017 Are there any predictors of hypertensive crisis? Agulova, L.P.
1998
11 4S1 p. 162A-
1 p.
artikel
564 G014 Augmentation of glomerular filtration by portal venous infusion of free fatty acid Ise, T.
1998
11 4S1 p. 161A-
1 p.
artikel
565 G005 Blood pressure and vascular function following space flight Hatton, D.C.
1998
11 4S1 p. 159A-
1 p.
artikel
566 G001 Cerebral blood flow in hypertensives: An initial report of reduced and compensatory blood flow responses during performance of two cognitive tasks Jennings, J.R.
1998
11 4S1 p. 134A-
1 p.
artikel
567 G002 Cognitive apraisal of threat or challenge predicts hemodynamic responses to mental arithmetic and speech tasks Allen, K.
1998
11 4S1 p. 134A-
1 p.
artikel
568 G006 Correlates of blood pressure control in a population-based sample of rural women Eaker, E.D.
1998
11 4S1 p. 135A-
1 p.
artikel
569 G001 Dynamics of the local vascular response to cold pressor test is different in two types of essential human hypertension Bochmann, R.P.
1998
11 4S1 p. 158A-
1 p.
artikel
570 G011 Effect of parathyroid hypertensive factor on the heart Lewanczuk, R.Z.
1998
11 4S1 p. 160A-
1 p.
artikel
571 G004 Effects of melatonin after an eastward transmeridian flight on ambulatory blood pressure monitoring of normotensive subjects Lusardi, P.
1998
11 4S1 p. 134A-
1 p.
artikel
572 Gender modifies the relationship between awake systolic blood pressure and growth in adolescents Lurbe, E.
1998
11 4S1 p. 20A-
1 p.
artikel
573 Gender perspectives on hypertension Taylor, Anne L.
1998
11 4S1 p. 255A-
1 p.
artikel
574 Genetic analysis of the susceptibility to develop renal damage after unilateral nephrectomy in rats Provoost, A.P.
1998
11 4S1 p. 5A-
1 p.
artikel
575 Genetic aspects of response to treatment and choice of therapy — new opportunities to individualize treatment? Williams, Gordon H.
1998
11 4S1 p. 247A-
1 p.
artikel
576 Genetic mapping of soluble guanylyl cyclase genes: Implications for linkage to blood pressure in the Dahl rat Gupta, G.
1998
11 4S1 p. 5A-
1 p.
artikel
577 Genetics of hypertension in a Spanish population. Results from epidemiologic study, with a case-control population-based design Martinez, Esperanza
1998
11 4S1 p. 6A-
1 p.
artikel
578 G006 Estimation of papillary muscle volume and relationship to left ventricular volume in normal hypertrophic and cardiomyopathic ventricles: A transesophageal echocardiographic study Madu, E.
1998
11 4S1 p. 159A-
1 p.
artikel
579 G008 Fibrinogen and whole blood low shear viscosity in essential hypertension Taes, Y.
1998
11 4S1 p. 159A-
1 p.
artikel
580 G016 High pulse wave velocity in hypertensives are associated with increased vascular stiffness and wave reflections Li, John K.-J.
1998
11 4S1 p. 161A-
1 p.
artikel
581 G012 Hypertension-related hypalgesia and family history of hypertension Guasti, L.
1998
11 4S1 p. 160A-
1 p.
artikel
582 G015 Improving arterial system compliance in hypertension through increasing blood flow Matonick, John P.
1998
11 4S1 p. 161A-
1 p.
artikel
583 G003 Influence of aging social support and pet ownership on blood pressure in women at home and in physicians offices Allen, K.
1998
11 4S1 p. 134A-
1 p.
artikel
584 G010 Inhibition of central renin-induced water intake by the angiotensin II AT1 receptor blocker, irbasertan Ma, L.Y.
1998
11 4S1 p. 160A-
1 p.
artikel
585 G007 Interactions of social support and family history in blood pressure reactivity to psychological stressors Shykoff, B.E.
1998
11 4S1 p. 135A-
1 p.
artikel
586 G009 Is blood pressure related to kidney size in children? Perry, K.
1998
11 4S1 p. 160A-
1 p.
artikel
587 G018 Many-days cyclicity and mutual sinchronization of hemodynamic and vegetative functions in patients with essential hypertension Agulova, L.
1998
11 4S1 p. 162A-
1 p.
artikel
588 G002 Non-invasive measurement of aortic impedance in humans: Changes with β-blockade and heart rate Gatzka, C.D.
1998
11 4S1 p. 158A-
1 p.
artikel
589 G003 Oxidative stress during maximal exercise in physically active patients with essential hypertension Predel, H.G.
1998
11 4S1 p. 158A-
1 p.
artikel
590 G004 Plasma leptin levels in patients with essential hypertension - modulatory effects of maximal and submaximal exercise Schramm, T.
1998
11 4S1 p. 158A-
1 p.
artikel
591 G005 Prevalence of hypertension in smokers: The polish hypertension survey Szczech, R.
1998
11 4S1 p. 135A-
1 p.
artikel
592 G007 Responsiveness to forskolin is reduced in isolated hearts of obese rabbits Carroll, J.F.
1998
11 4S1 p. 159A-
1 p.
artikel
593 G013 Treatment with enalapril increases experimental pain sensitivity in hypertensive patients Guasti, L.
1998
11 4S1 p. 161A-
1 p.
artikel
594 H009 Age, hypertension and cardiac responses to β-agonist in humans Leenen, F.H.H.
1998
11 4S1 p. 165A-
1 p.
artikel
595 H001 Alteration of alpha- and beta- adrenoceptor subtypes in different animal models of simultaneously occuring diabetes - mellitus and hypertension Goyal, R.K.
1998
11 4S1 p. 163A-
1 p.
artikel
596 H010 Association of essential hypertension with polymorphisms in the β 2-adrenergic receptor Herrmann, V.
1998
11 4S1 p. 165A-
1 p.
artikel
597 H016 Autonomic nervous dysfunction as an end-organ damage in essential hypetensive patients: Evaluation by power spectral analysis of heart rate variability Kohara, K.
1998
11 4S1 p. 166A-
1 p.
artikel
598 H014 Autonomic nervous system activity in borderline hypertension Michieletto, M.
1998
11 4S1 p. 166A-
1 p.
artikel
599 H017 Baroreflex sensitivity and the occurrence of neurocardiogenic syncope Freitas, J.
1998
11 4S1 p. 167A-
1 p.
artikel
600 H011 Comparative effects of verapamil and amlodipine on modulation of autonomic nervous system in healthy volunteers Joannides, R.
1998
11 4S1 p. 165A-
1 p.
artikel
601 H003 Different blood pressure regulatory mechanisms between obesity and hypertension Masuo, K.
1998
11 4S1 p. 163A-
1 p.
artikel
602 Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension White, William B.
1998
11 4S1 p. 254A-
1 p.
artikel
603 Heart rate data from the VA cooperative study Materson, Barry J.
1998
11 4S1 p. 252A-
1 p.
artikel
604 H002 Effects of clonidine on power spectral analysis of heart rate variability in mild essential hypertension Lazzeri, Chiara
1998
11 4S1 p. 163A-
1 p.
artikel
605 H006 Heart rate and blood pressure variability in hypertensive patients Tasić, I.S.
1998
11 4S1 p. 164A-
1 p.
artikel
606 H007 Heart rate variability and left ventricular morphology and function in borderline and stable essential hypertension Martini, G.
1998
11 4S1 p. 164A-
1 p.
artikel
607 History of hypertension has a great predictive value toward one-year mortality after acute myocardial infarction, but only in patients with microalbuminuria Berton, G.
1998
11 4S1 p. 26A-
1 p.
artikel
608 H012 J-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: Orthostatic hypertension as a new cerebrovascular risk factor Karlo, K.
1998
11 4S1 p. 165A-
1 p.
artikel
609 H008 Nitric oxide component present in β-adrenergic vasodilation is impaired in essential hypertension Vecchione, C.
1998
11 4S1 p. 164A-
1 p.
artikel
610 H013 Noradrenaline and insulin: Pathogenic factors in the hypertension of Mexican American families Lee, D.P.
1998
11 4S1 p. 166A-
1 p.
artikel
611 Hormonal determinants of salt sensitive hypertension Romero, J.Carlos
1998
11 4S1 p. 243A-
1 p.
artikel
612 Hormone replacement therapy and blood pressure: The PEPI study Langer, Robert D.
1998
11 4S1 p. 239A-
1 p.
artikel
613 Hormone replacement therapy use and blood pressure: Results from the health surveys for England 1993 and 1994 Colhoun, H.
1998
11 4S1 p. 4A-
1 p.
artikel
614 How effective is our management of hypertension? Elliott, W.J.
1998
11 4S1 p. 247A-
1 p.
artikel
615 H015 Predictive power of heart rate for cardiovascular mortality in the elderly Palatini, P.
1998
11 4S1 p. 166A-
1 p.
artikel
616 H004 Regulation of adenylyl cyclase (AC) type 9 in madin darby canine (MDCK) cells by native alpha2A-adrenoceptors (α 2A-ARs). Sensitization of AC9 is mediated by protein kinase C (PKC) Mangrum, A.I.
1998
11 4S1 p. 163A-
1 p.
artikel
617 H002 Risk factors for hypertension among urban Zimbabwean subjects: Female gender biased? Djewole, John A.O.
1998
11 4S1 p. 136A-
1 p.
artikel
618 H001 safety of dipyridamole stress radionuclide myocardial perfusion study in patients with symptomatic carotid artery stenosis Tabriz, A.N.
1998
11 4S1 p. 136A-
1 p.
artikel
619 H018 Sympathetic neural activation in skeletal muscle correlates with abdominal obesity in healthy, young African-American women Abate, N.
1998
11 4S1 p. 167A-
1 p.
artikel
620 Hunting for genes of hypertension: A novel paradigm Cowley Jr., A.W.
1998
11 4S1 p. 242A-
1 p.
artikel
621 H005 Venous diameter changes to isometric exercise reflect systemic blood pressure Vavilala, V.
1998
11 4S1 p. 164A-
1 p.
artikel
622 Hypertension and changes in the aortic adventitia Brecher, Peter
1998
11 4S1 p. 238A-
1 p.
artikel
623 Hypertension, cardiac arrhythmias, and sudden death Messerli, F.H.
1998
11 4S1 p. 250A-
1 p.
artikel
624 I017 Circadian stage-dependent erythropoietin effects on rats' blood pressure hematocrit and body weight Lee, M.S.
1998
11 4S1 p. 172A-
1 p.
artikel
625 I027 Circulating levels of cardiac natriuretic peptides measured by highly sensitive and specific IRMA methods in normal subjects and in patients with heart failure Clerico, Aldo
1998
11 4S1 p. 174A-
1 p.
artikel
626 I016 Complex hemodynamic changes in vivo after adrenomedullin (ADM) administration in rats Vijay, P.
1998
11 4S1 p. 171A-
1 p.
artikel
627 I001 C-type natriuretic peptide does not affect plasma and urinary adreno-medullin in man Lazzeri, Chiara
1998
11 4S1 p. 168A-
1 p.
artikel
628 I025 Cyclooxygenase is the main source of oxydative stress in essential hypertension L., Ghiadoni
1998
11 4S1 p. 174A-
1 p.
artikel
629 Identical responses to similar plasma and II levels produced by exogenous renin or exogenous ang II infusion in conscious rats Hu, L.
1998
11 4S1 p. 18A-
1 p.
artikel
630 Identification of adrenomedullin as a candidate gene in the stroke-prone phenotype of spontaneously hypertensive rats (SHRSP) Rubattu, S.
1998
11 4S1 p. 5A-
1 p.
artikel
631 Identifying the prevalence and consequences of sub-optimal compliance Urquhart, John
1998
11 4S1 p. 248A-
1 p.
artikel
632 I005 Diffuse severe epicardial constriction after acetylcholine: A global but reversible deficiency of nitric oxide Houghton, J.L.
1998
11 4S1 p. 169A-
1 p.
artikel
633 I028 Dissociation between the increments of plasma and urinary cyclic GMP during saline infusion in essential hypertensive patients Sala, C.
1998
11 4S1 p. 174A-
1 p.
artikel
634 I006 Does plasma endothelin (ET)-I reflect renal hypoperfusion? Studies in patients before and after infrarenal aortic cross-clamping Heldbreder, E.
1998
11 4S1 p. 169A-
1 p.
artikel
635 I015 Dynamics of prostacyclin, thromboxane A2, and F2-isoprostanes and influence of eicosapentaenoic acid in patients with hyperlipidemia Yamada, M.
1998
11 4S1 p. 171A-
1 p.
artikel
636 I012 Effect of heme oxygenase inhibition on blood pressure Santos, E.A.
1998
11 4S1 p. 170A-
1 p.
artikel
637 I029 Effect of parathyroid hypertensive factor on vascular smooth muscle cell proliferation in WKY rats Shan, J.
1998
11 4S1 p. 175A-
1 p.
artikel
638 I002 Effects of atrial (ANP) and C-type (CNP) natriuretic peptide on the renal release of endothelin-1 (ET-1) in man La Villa, Giorgio
1998
11 4S1 p. 168A-
1 p.
artikel
639 I004 Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension Pierdomenico, S.D.
1998
11 4S1 p. 168A-
1 p.
artikel
640 I018 Endothelin-1 released by vascular smooth muscle cells (VSMCS) enhances vascular responsiveness of rat mesenteric arterial bed (MA) exposed to high perfusion flow (HPF) Russo, D.
1998
11 4S1 p. 172A-
1 p.
artikel
641 I013 Endothelins and urinary parameters in hypertensive patients Rueda, D.
1998
11 4S1 p. 171A-
1 p.
artikel
642 I008 Endothelium dependent vasodilation is reduced in middle aged non-dipper hypertensive patients Miyoshi, A.
1998
11 4S1 p. 169A-
1 p.
artikel
643 I030 Enzyme immunoassay of parathyroid hypertensive factor for clinical application Krylova, S.M.
1998
11 4S1 p. 175A-
1 p.
artikel
644 I011 Estrogen may influence blood pressure regulation Sung, B.H.
1998
11 4S1 p. 170A-
1 p.
artikel
645 I007 Gender and racial differences in efficacy of intracoronaryl-arginine Houghton, J.L.
1998
11 4S1 p. 169A-
1 p.
artikel
646 I033 Hypertension associated with obstructive sleep apnea: Possible role of endothelin Cases, A.
1998
11 4S1 p. 176A-
1 p.
artikel
647 I032 Impaired flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients Hausberg, M.
1998
11 4S1 p. 175A-
1 p.
artikel
648 I024 Increase of endothelin binding sites in placental bed in preeclampsia Ferreira-de-Almeida, J.A.
1998
11 4S1 p. 173A-
1 p.
artikel
649 I009 Metabolic and blood pressure lowering effects of l-arginine supplements in men Siani, A.
1998
11 4S1 p. 170A-
1 p.
artikel
650 Impact of newer antihypertensive agents on the management of hypertension Black, H.R.
1998
11 4S1 p. 250A-
1 p.
artikel
651 Impaired endothelium- and sodium pump-mediated hyperpolarization in mesenteric bed of doca-salt hypertensive rats Adeagbo, A.S.O.
1998
11 4S1 p. 27A-
1 p.
artikel
652 Impairment of cyclosporine-induced sympathetic activation in knockout mice lacking synapsins Victor, Ronald G.
1998
11 4S1 p. 29A-
1 p.
artikel
653 Implications of the syst-eur and SHEP trials in the treatment of systolic hypertension Cushman, William C.
1998
11 4S1 p. 253A-
1 p.
artikel
654 Importance of time of drug administration and the time and duration of blood pressure control Morgan, T.O.
1998
11 4S1 p. 241A-
1 p.
artikel
655 Improved blood pressure control in hypertensive and hypercholesterolemic patients treated with HMG-CoA reductase inhibitors Bacchelli, S.
1998
11 4S1 p. 25A-
1 p.
artikel
656 Inappropriate left ventricular mass and ambulatory blood pressure in arterial hypertension Palmieri, V.
1998
11 4S1 p. 3A-
1 p.
artikel
657 I003 Natriuretic peptides and endothelin during atrial pacing in hypertensive patients with coronary artery disease Di Donato, Marisa
1998
11 4S1 p. 168A-
1 p.
artikel
658 Incomplete normalization of left ventricular mass in well-controlled hypertension Schillaci, G.
1998
11 4S1 p. 3A-
1 p.
artikel
659 Increased renal resistive index in patients with essential hypertension: A marker of intrarenal atherosclerosis? Pontremoli, R.
1998
11 4S1 p. 30A-
1 p.
artikel
660 1998 Index of abstract authors 1998
11 4S1 p. 266A-280A
nvt p.
artikel
661 Influence of blood volume (BV) changes on blood pressure and endothelin-1 (ET-1) concentration during hemodialysis (HD) treatment Stefanidis, I.
1998
11 4S1 p. 14A-
1 p.
artikel
662 Influence of glucose tolerance on the age-associated decline in glomerular filtration rate in essential hypertension Ribstein, J.
1998
11 4S1 p. 30A-
1 p.
artikel
663 Inhibition of restenosis lesion formation in the swine coronary artery by dietary potassium Young, D.B.
1998
11 4S1 p. 11A-
1 p.
artikel
664 I022 Non-invasive assessment of endothelial dysfunction in essential hypertension Muiesan, M.L.
1998
11 4S1 p. 173A-
1 p.
artikel
665 Insulin's stimulation of cGMP production and inhibition of contraction of cultured vascular smooth muscle (VSM) cells require the permissive presence of basal nitric oxide synthase (NOS) activity Kahn, Andrew M.
1998
11 4S1 p. 27A-
1 p.
artikel
666 Integrative mechanisms in congestive heart failure Manolis, A.J.
1998
11 4S1 p. 236A-
1 p.
artikel
667 Intraglomerular hypertension and hyperfiltration due to impaired renal autoregulation in the fawn-hooded hypertensive (FHH) rat VanDokkum, R.P.E.
1998
11 4S1 p. 1A-
1 p.
artikel
668 I026 Plasma levels of natriuretic peptides and adrenomedullin elderly hypertensives: Relationships with 24-hr blood pressure Kario, K.
1998
11 4S1 p. 174A-
1 p.
artikel
669 I010 Relationship of plasma natriuretic hormone content and cardiac cavities dimension in essential hypertension patients Bobrova, E.V.
1998
11 4S1 p. 170A-
1 p.
artikel
670 Is a high heart rate associated with a faster progression of chronic renal failure? Mora-Maciá, J.
1998
11 4S1 p. 23A-
1 p.
artikel
671 I014 SB 209670, a mixed ETA/ETB receptor antagonist, lowers blood pressure in patients with essential hypertension Freed, M.I.
1998
11 4S1 p. 171A-
1 p.
artikel
672 I019 Secretion pattern of natriuretic peptides in hypertensives with asymmetric septal hypertrophy Hamada, M.
1998
11 4S1 p. 172A-
1 p.
artikel
673 I034 Serum levels of nitric oxide and urinary excretion of cGMP in amlodipine-treated hypertensive patients Puentes-Arciniegas, F.F.
1998
11 4S1 p. 176A-
1 p.
artikel
674 Is insulin-induced growth of vascular smooth muscle cells mediated by the insulin-like growth factor receptor? Kamide, K.
1998
11 4S1 p. 11A-
1 p.
artikel
675 I021 The humoral, haemodynamic and renal effects of exogenous atrial natriuretic peptide are enhanced by low-calorie diet and weight loss in obese hypertensives Dessì-Fulgheri, P.
1998
11 4S1 p. 173A-
1 p.
artikel
676 I023 The role of 20-hydroxyeicosa tetraenoic acid (20-HETE) in nitric oxide (NO)-mediated regulation of renal function and blood pressure Oyekan, A.O.
1998
11 4S1 p. 173A-
1 p.
artikel
677 I020 Urinary levels of tissue kallikrein in black and Indian hypertensives and its implications to therapy Seedat, Y.K.
1998
11 4S1 p. 172A-
1 p.
artikel
678 I031 “Vascular endotelial disfunction, in relation from cardio-vascular system” cardiology service-militar hospital quito-ecuador S.A. González, C.L.
1998
11 4S1 p. 175A-
1 p.
artikel
679 I035 Vascular resistance in patients with HELLP-syndrome and preeclampsia Schneider, M.P.
1998
11 4S1 p. 176A-
1 p.
artikel
680 J011 Abnormalities of renal functional reserve in patients with mild heart failure are corrected by losartan Rao, M.A.E.
1998
11 4S1 p. 179A-
1 p.
artikel
681 J015 Acute hypotensive and natriuretic effects of nifedipine in black normotensive and hypertensive subjects Damasceno, A.
1998
11 4S1 p. 180A-
1 p.
artikel
682 J004 Blood pressure and renal hemodynamics during infusion of amino acid solution or clonidine in different renal disease Heidbreder, E.
1998
11 4S1 p. 177A-
1 p.
artikel
683 J019 Clinical and biochemical factors associated with the presence of microalbuminuria in a group of essential hypertensive patients De la Sierra, A.
1998
11 4S1 p. 181A-
1 p.
artikel
684 J003 Early renal damage in postmenopausal hypertensive woman Palmiero, P.
1998
11 4S1 p. 177A-
1 p.
artikel
685 J007 Enalapril (E) improves urine albumin excretion (UAE) in rats with tubulointerstitial (TI) lesions by hyperoxaluria (Hox.) Toblli, J.E.
1998
11 4S1 p. 178A-
1 p.
artikel
686 J020 Endogenous lithium clearance to assess the salt-dependent changes in renal sodium handling: Effect of acute water loading Monod, M.L.
1998
11 4S1 p. 181A-
1 p.
artikel
687 J018 Feasibility of color doppler ecography of renal arteries simultaneously with routine echocardiographic evaluation of hypertensive patients Mori, F.
1998
11 4S1 p. 181A-
1 p.
artikel
688 J013 Influence of circadian blood pressure variations (CBPV) on renal function in essential hypertension Ivanov, M.V.
1998
11 4S1 p. 180A-
1 p.
artikel
689 J008 Lack of racial variation in renal and systemic hemodynamic responses to infused endothelin-1(ET-1) Freed, M.I.
1998
11 4S1 p. 178A-
1 p.
artikel
690 J002 Lipoprotein profile and microalbuminuria in salt-sensitive and no salt-sensitive hypertensive patients Martin-Sanz, V.
1998
11 4S1 p. 177A-
1 p.
artikel
691 J005 Relationship between parathormone levels and arterial distensibility in renal transplant recipients Barenbrock, M.
1998
11 4S1 p. 178A-
1 p.
artikel
692 J009 Renal effects of valsartan and benazepril in healthy volunteers Fumeron, C.
1998
11 4S1 p. 179A-
1 p.
artikel
693 J016 Role of the renal dopaminergic system in the responses to sodium load in salt-sensitive and salt-resistant black normotensives and hypertensives Damasceno, A.
1998
11 4S1 p. 180A-
1 p.
artikel
694 J001 Selective modulation by calcium-channel blocker manidipine on renal hemodynamic effects of nitric oxide inhibition in humans Montanari, A.
1998
11 4S1 p. 177A-
1 p.
artikel
695 J010 Serum creatinine level underestimates hypertensive renal involvement in elderly hypertensive patients Shigematsu, Y.
1998
11 4S1 p. 179A-
1 p.
artikel
696 J012 Sodium external balance and RBC K (Ki) in hypertensives receiving indapamide Delgado-Almeida, A.R.
1998
11 4S1 p. 179A-
1 p.
artikel
697 J017 Ultrasound evaluation of target organ abnormalities in hypertensive patients Mori, F.
1998
11 4S1 p. 181A-
1 p.
artikel
698 J014 Urinary glycosaminoglicans decrease before the reduction of urinary albumin excretion during simvastatin therapy in type II hypertensive diabetic patients Tonolo, G.
1998
11 4S1 p. 180A-
1 p.
artikel
699 J006 Urinary 92 kDa gelatinase excretion, a novel marker of early diabetic nephropathy in hypertensive type 2 diabetic patients : modulation by amlodipine or ACE inhibitor, captopril Zaoui, P.
1998
11 4S1 p. 178A-
1 p.
artikel
700 K023 Abnormal left ventricular structure and function in pregnancy complicated by pre-aclampsia Degli Esposti, D.
1998
11 4S1 p. 188A-
1 p.
artikel
701 K025 Aortic pulse wave velocity (PWV): Marker of cardiovascular risk in hypertensive patients Blacher, J.
1998
11 4S1 p. 189A-
1 p.
artikel
702 K014 Association of RBC sodium-lithium countertransport with left ventricular mass in African American women Sherif, K.
1998
11 4S1 p. 186A-
1 p.
artikel
703 K008 Brachial artery compliance decreases during pregnancy Grossman, E.B.
1998
11 4S1 p. 184A-
1 p.
artikel
704 K013 Clinical determinants of coronary flow reserve in essential hypertension Matsuzaki, K.
1998
11 4S1 p. 186A-
1 p.
artikel
705 K016 Coronary artery size of left main trunk in patients with essential hypertension is not adequately matched to left ventricular hypertrophy Okayama, H.
1998
11 4S1 p. 186A-
1 p.
artikel
706 K038 Correlations between essential hypertension and morphological and function changes in the carotid arteries Dorobantu, M.
1998
11 4S1 p. 192A-
1 p.
artikel
707 K029 Depressed extracellular degradation of collagen type 1 in patients with essential hypertension and left ventricular hypertrophy Laviades, C.
1998
11 4S1 p. 190A-
1 p.
artikel
708 K037 Depressed left ventricular performance in essential hypertension: The role of 24-hour BP Schillaci, G.
1998
11 4S1 p. 192A-
1 p.
artikel
709 K001 Depressed midwall fractional shortening predicts diastolic dysfunction in asymptomatic hypertensive patients Schussheim, A.E.
1998
11 4S1 p. 183A-
1 p.
artikel
710 K034 Different correlates of carotid artery lesions (CAL) and intimal-medial thickness (IMT) in primary hypertensives (PH) Rossi, A.
1998
11 4S1 p. 191A-
1 p.
artikel
711 K005 Different fat metabolism in hypertension and fat loading hyperviscosity related circulatory load Cinar, Y.
1998
11 4S1 p. 184A-
1 p.
artikel
712 K041 Duration of hypertension and vascular changes in essential hypertensives Amar, J.
1998
11 4S1 p. 193A-
1 p.
artikel
713 K024 ECG detection of left ventricular hypertrophy is better in blacks than whites Chapman, J.N.
1998
11 4S1 p. 188A-
1 p.
artikel
714 K006 Effect of hematocrit on blood pressure via hyperviscosity Çinar, Y.
1998
11 4S1 p. 184A-
1 p.
artikel
715 K039 Effect of hypertension on structure and hemodynamic characteristics in common carotid artery Jiang, Y.N.
1998
11 4S1 p. 192A-
1 p.
artikel
716 K032 High-normal blood pressure: An instrumental approach Mettimano, M.
1998
11 4S1 p. 190A-
1 p.
artikel
717 K026 Impact of aortic stiffness on survival in end-stage renal failure Blacher, J.
1998
11 4S1 p. 189A-
1 p.
artikel
718 K018 Impact of coronary blood flow on negative T wave in patients with hypertension: using thallium-201 myocardial scintigraphy Kuwahara, T.
1998
11 4S1 p. 187A-
1 p.
artikel
719 K015 Impaired elastin synthesis in early life as a cause of adult hypertension Martyn, C.N.
1998
11 4S1 p. 186A-
1 p.
artikel
720 K031 In borderline hypertensives of the harvest, physical activity is associated with increased carotid intima-media thickness Pauletto, P.
1998
11 4S1 p. 190A-
1 p.
artikel
721 K017 Incidence and prognostic relevance of silent myocardial ischemia (SMI) in essential arterial hypertension (EAH) associated with hyperlipemia Melina, D.
1998
11 4S1 p. 187A-
1 p.
artikel
722 K004 Insulin sensitivity is related to exercise capacity and exercise blood pressure to structural vascular properties in young men Fossum, E.
1998
11 4S1 p. 183A-
1 p.
artikel
723 K036 Left ventricular geometry and function in patients with essential hypertension and microalbuminuria Pontremoli, R.
1998
11 4S1 p. 191A-
1 p.
artikel
724 K021 Left ventricular mass and circulating growth factors in essential hypertension Cottone, S.
1998
11 4S1 p. 188A-
1 p.
artikel
725 K030 Left ventricular remodeling in African Americans is not explained by a blunted noctural blood pressure fall in salt sensitive subjects Hinderliter, A.L.
1998
11 4S1 p. 190A-
1 p.
artikel
726 K035 Microalbuminuria is an early marker of target organ damage in essential hypertension Pontremoli, R.
1998
11 4S1 p. 191A-
1 p.
artikel
727 K019 Non invasive parameters of arterial dysfunction in borderline hypertensives Espinosa, J.Diego
1998
11 4S1 p. 187A-
1 p.
artikel
728 K027 Obesity and left ventricular diastolic dysfunction: Noninvasive study on normotensives and never-treated hypertensives Piantanida, E.
1998
11 4S1 p. 189A-
1 p.
artikel
729 K040 Regional adipose tissue distribution, left ventricular mass, and hyperinsulinaema in nonobese hypertensive subjects Rizzo, V.
1998
11 4S1 p. 192A-
1 p.
artikel
730 K033 Relationship between cardiovascular reactivity of heart rate and blood pressure to a structured stressful interview and early target organ damage in untreated mild hypertension hospitalet study Amario, P.
1998
11 4S1 p. 191A-
1 p.
artikel
731 K042 Relationship between systolic and diastolic blood pressure and left ventricular systolic and diastolic function in patients with essential hypertension Qi, Hua
1998
11 4S1 p. 193A-
1 p.
artikel
732 K011 Remodeling of carotid and brachial arteries in patients with essential hypertension Mukai, M.
1998
11 4S1 p. 185A-
1 p.
artikel
733 K012 Reproducibility of measures of parital thickening and of carotid diameter by a new automatic analysis programme Baguet, J.Ph.
1998
11 4S1 p. 185A-
1 p.
artikel
734 K020 Reversal of cardiac hypertrophy improves midwall systolic performance Muiesen, M.L.
1998
11 4S1 p. 187A-
1 p.
artikel
735 K003 Silent cerebrovascular abnormalities in mild-to-moderate essential hypertension Sierra, C.
1998
11 4S1 p. 183A-
1 p.
artikel
736 K010 Studying of the correlation between ambulatary blood pressure monitoring and left ventricular function in patients with essential hypertension Hua, Qi
1998
11 4S1 p. 185A-
1 p.
artikel
737 K022 The carotid artery intima-media thickness is related to the distal arterial compliance but not to the proximal arterial compliance Duprez, D.
1998
11 4S1 p. 188A-
1 p.
artikel
738 K007 The effect of long-term treatment with verapamil in coronary artery disease patients with hypertension and heart rate variability Simorot, V.
1998
11 4S1 p. 184A-
1 p.
artikel
739 K009 The relationship between left ventricular hypertrophy and magnesium deficiency in patients with essential hypertension Mori, H.
1998
11 4S1 p. 185A-
1 p.
artikel
740 K028 Ultrasonic myocardial textural analysis of hypertensive heart: Comparison with pulsed doppler analysis of transmitral flow Di Bello, V.
1998
11 4S1 p. 189A-
1 p.
artikel
741 K002 What causes exercise induced breathlessness in hypertensive patients? Lim, P.O.
1998
11 4S1 p. 183A-
1 p.
artikel
742 L004 Ace polymorphisms influences microalbuminura in essential hypertension Redon, J.
1998
11 4S1 p. 194A-
1 p.
artikel
743 Lack of association between β2 adrenoceptor polymorphism and essential hypertension in a black African population Cockcroft, John R.
1998
11 4S1 p. 6A-
1 p.
artikel
744 L013 Altered phenotype of the renin-angiotensin aldosterone system in normo- and hypertensive patients genotyped for the angiotensin II type I (ATI)-receptor polymorphism Spiering, W.
1998
11 4S1 p. 197A-
1 p.
artikel
745 L015 Arterial hypertension in relation to the insertion/deletion polymorphism of the ACE gene in patients with coronary heart disease in different age groups Gruchala, M.
1998
11 4S1 p. 197A-
1 p.
artikel
746 L009 Association of ACE gene polymorphism with HDL level and blood pressure variability in stage I hypertensives Winnicki, M.
1998
11 4S1 p. 196A-
1 p.
artikel
747 L006 Association of angiotensin converting enzyme gene polymorphism with carotid arterial wall thickness Ferrières, J.
1998
11 4S1 p. 195A-
1 p.
artikel
748 L008 Association of TRP64ARG beta 3-adrenergic-receptor gene polymorphism with essential hypertension in Sardinia Tonolo, G.
1998
11 4S1 p. 195A-
1 p.
artikel
749 Late ace inhibitor treatment protects old SHR from cardiovascular death Linz, W.
1998
11 4S1 p. 12A-
1 p.
artikel
750 L018 Distribution of differential HLA antigens in Greek hypertensives according to the angiotensin-converting enzyme genotype Diamantopoulos, E.J.
1998
11 4S1 p. 198A-
1 p.
artikel
751 Left ventricular systolic function in hypertensive patients with ECG determined left ventricular hypertrophy: The life study Wachtell, K.
1998
11 4S1 p. 2A-
1 p.
artikel
752 L010 Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients Kario, K.
1998
11 4S1 p. 196A-
1 p.
artikel
753 Leptin and the new biology of obesity: implications for hypertension Mark, A.L.
1998
11 4S1 p. 241A-
1 p.
artikel
754 L005 Heritability of blood pressure and blood pressure determinants in hypertensive-dyslipidemic African Americans Nadig, V.
1998
11 4S1 p. 195A-
1 p.
artikel
755 Lifestyle and blood pressure — An overview Beilin, L.J.
1998
11 4S1 p. 237A-
1 p.
artikel
756 L002 Influence of angiotensin II type 1 receptor A/C1166 polymorphism on hypertension in patients with and without coronary atherosclerosis Saku, K.
1998
11 4S1 p. 194A-
1 p.
artikel
757 Lipoxygenase-derived eicosanoids Tuck, Michael L.
1998
11 4S1 p. 235A-
1 p.
artikel
758 L003 Lack of association between the α-adducin locus and essential hypertension in the Japanese population Kato, N.
1998
11 4S1 p. 194A-
1 p.
artikel
759 L011 Lack of association between the polymorphism of ACE gene and microalbuminuria (MA) López-Contreras, J.
1998
11 4S1 p. 196A-
1 p.
artikel
760 L012 Left ventricular hypertrophy and angiotensin converting enzyme gene polymorphism Karpov, R.
1998
11 4S1 p. 196A-
1 p.
artikel
761 L007 Low RBC K (Ki): A possible intermediate phenotype for essential hypertension Delgado-Leon, M.C.
1998
11 4S1 p. 195A-
1 p.
artikel
762 Localization of a gene for blood pressure regulation to human chromosome 18q DeStefano, A.L.
1998
11 4S1 p. 5A-
1 p.
artikel
763 L015 Role of angiotensin II type 1 (ATI)-receptor polymorphism in women with a history of preeclampsia (PE) Spiering, W.
1998
11 4S1 p. 197A-
1 p.
artikel
764 L001 Serum paraoxonase activity in essential hypertension Pierdomenico, S.D.
1998
11 4S1 p. 194A-
1 p.
artikel
765 L017 The associations between some risk factors & blood pressure in men with essential arterial hypertension Matveeva, S.A.
1998
11 4S1 p. 198A-
1 p.
artikel
766 L016 The interrelationship of blood pressure & lipid metabolism in women with ischaemic heart disease & arterial hypertension Matveeva, S.A.
1998
11 4S1 p. 197A-
1 p.
artikel
767 Management of elderly patients with systolic blood pressure 140–159 mmHg Black, H.R.
1998
11 4S1 p. 253A-
1 p.
artikel
768 Management of hypertension in African-Americans, lifestyle modifications and pharmacologic approaches Ferdinand, Keith C.
1998
11 4S1 p. 255A-
1 p.
artikel
769 M018 Apparent mineralocorticoid excess syndrome (AMES): 20 year follow-up in four patients Tedde, R.
1998
11 4S1 p. 203A-
1 p.
artikel
770 Mapping cardiovascular mortality in the United States Pickle, Linda Williams
1998
11 4S1 p. 234A-
1 p.
artikel
771 M026 Azotemia caused by renal artery stenosis treatment by percutaneous angioplasty (PTRA) initial and long term results Sellem, S.
1998
11 4S1 p. 205A-
1 p.
artikel
772 M008 Changes in blood pressure (BP) in rats with uric acid nephropathy (UAN) Toblli, J.E.
1998
11 4S1 p. 200A-
1 p.
artikel
773 M021 Delayed recovery of circadian blood pressure (BP) rhythm after cardiac transplant (TX) compared to liver TX at one year Taler, S.J.
1998
11 4S1 p. 204A-
1 p.
artikel
774 M011 Dexamethasone suppression test and long-PCR of chimeric gene for the diagnosis of glucocorticoid-remediable aldosteronism (GRA) in patients with primary aldosteronism (PA) Mulatero, P.
1998
11 4S1 p. 201A-
1 p.
artikel
775 Mechanical forces and myocyte death Anversa, Piero
1998
11 4S1 p. 236A-
1 p.
artikel
776 Mechanisms of hypertension — Opportunities to individualize on the basis of pathophysiology and pharmacokinetics Sica, Domenic A.
1998
11 4S1 p. 246A-
1 p.
artikel
777 Mechanisms of renal dysfunction in obesity and role in hypertension Hall, John E.
1998
11 4S1 p. 241A-
1 p.
artikel
778 M015 Follow up of 123 patients submitted to adrenalectomy in primary aldosteronism Pego, Mariano
1998
11 4S1 p. 202A-
1 p.
artikel
779 M001 Hyperaldosteronism is a common cause of secondary hypertension missed by primary care physicians and associated with normokalemia Anwar, Y.Anis
1998
11 4S1 p. 199A-
1 p.
artikel
780 M023 Increased left ventricular mass (LVM) and diastolic dysfunction in normotensive young adults with autosomal dominant polycystic kidney disease (ADPKD). A prehypertensive state? Martinez-Vea, A.
1998
11 4S1 p. 204A-
1 p.
artikel
781 M017 Late diagnosis of renal vascular disease and renal damage in hypertension Livi, R.
1998
11 4S1 p. 203A-
1 p.
artikel
782 M020 Longitudinal hemodynamic study of hypertension in chronic renal parenchymal disease Kim, K.E.
1998
11 4S1 p. 203A-
1 p.
artikel
783 M010 Long-term survival of renovascular hypertension Omata, K.
1998
11 4S1 p. 201A-
1 p.
artikel
784 M013 Parallel changes in blood pressure and noradrenaline levels in a clinical model of acute hypothyroidism Fommei, E.
1998
11 4S1 p. 202A-
1 p.
artikel
785 M009 Post-captopril intra-renal Doppler waveform analysis as a screening tool for functionally significant renovascular disease Bloch, M.J.
1998
11 4S1 p. 201A-
1 p.
artikel
786 M014 Pulse pressure and malnutrition are the main determinants of vascular damage in dialysis patients Benedetto, F.A.
1998
11 4S1 p. 202A-
1 p.
artikel
787 M012 Renovascular hypertension: Long term follow up of surgical treatment Nanayakkara, L.S.
1998
11 4S1 p. 201A-
1 p.
artikel
788 MRI evidence for obesity-related cardiac and vascular hypertrophy in young black women Kizilbash, ali M.
1998
11 4S1 p. 2A-
1 p.
artikel
789 M002 Severe postpartum hypertension with reversible cerebral angiopathy associated with an ergot derivative (methergoline) administration Sverzellati, E.
1998
11 4S1 p. 199A-
1 p.
artikel
790 M025 Spiral CT angiography: Utility in renal arterial stenose Garcia-Ruiz, C.
1998
11 4S1 p. 205A-
1 p.
artikel
791 M022 Sympathetic activity and blood pressure pattern in ADPKD (Autosomal dominant polycystic kidney disease) hypertensives Cerasola, G.
1998
11 4S1 p. 204A-
1 p.
artikel
792 M005 Sympathetic nerve activity is enhanced in patients with pheochromocytoma Ashino, K.
1998
11 4S1 p. 200A-
1 p.
artikel
793 M016 The diagnosis of unilateral adrenal adenoma in 123 patients with primary aldosteronism Pego, Mariano
1998
11 4S1 p. 202A-
1 p.
artikel
794 M007 The effect of interdialytic weight gain on blood pressure in hemodialysis patients Rahman, M.
1998
11 4S1 p. 200A-
1 p.
artikel
795 M006 The role of hypertension in the genesis of cerebral atrophy in uremic patients Savazzi, G.M.
1998
11 4S1 p. 200A-
1 p.
artikel
796 M019 Ultrasonic videodensitometric analysis of myocardium in end-stage renal disease maintained in hemodialysis Di Bello, V.
1998
11 4S1 p. 203A-
1 p.
artikel
797 M003 Usefulness of helical CT angiography in the evaluation of renal artery stenosis Tovar, J.L.
1998
11 4S1 p. 199A-
1 p.
artikel
798 M024 Value and limitations of echo-Doppler velocimetric indices for diagnosing renal artery stenosis and assessing the effects of revascularization procedures Marana, I.
1998
11 4S1 p. 204A-
1 p.
artikel
799 N008 Benefits and barriers associated with exercise adherence in women with stage I hypertension Fish, A.
1998
11 4S1 p. 207A-
1 p.
artikel
800 N001 Blood pressure reduction with a program of JNC lifestyle modification and use of a reduced sodium salt containing potassium and magnesium in patients with hypertension Phillips, R.A.
1998
11 4S1 p. 206A-
1 p.
artikel
801 N009 Blood pressure throughout a division 1 swim season Paz, R.L.
1998
11 4S1 p. 208A-
1 p.
artikel
802 N014 Effect of a mineral salt diet on 24 hour blood pressure monitoring in elderly hypertensive patients Katz, A.
1998
11 4S1 p. 209A-
1 p.
artikel
803 N005 Effect of a prepared meal plan on trace mineral status in patients with cardiovascular disease risk factors Roullet, J.-B.
1998
11 4S1 p. 207A-
1 p.
artikel
804 N015 Effects of diltiazem on blood pressure and left ventricular mass in the very elderly hypertensives Zoppi, A.
1998
11 4S1 p. 209A-
1 p.
artikel
805 N011 Effects of intervall vs continuous running on postexercise blood pressure in normotensives Häsler, E.
1998
11 4S1 p. 208A-
1 p.
artikel
806 N006 Effects of two dietary interventions on weight and blood pressure in overweight hypertensive patients McCarron, D.A.
1998
11 4S1 p. 207A-
1 p.
artikel
807 Neurological degeneration/post-urological surgical complications Steers, William D.
1998
11 4S1 p. 257A-
1 p.
artikel
808 N017 Hemodynamic (HD) change at rest and activity during weight loss in morbidly obese hypertensive patients Zimlichman, R.
1998
11 4S1 p. 210A-
1 p.
artikel
809 N016 Hemodynamic responses from the accumulation of short bouts of moderate-intensity physical activity in hypertensive, post-menopausal women Staffileno, B.A.
1998
11 4S1 p. 209A-
1 p.
artikel
810 N003 Life-style modifications reduce blood pressure and antihypertensive drug requirements Legg, V.
1998
11 4S1 p. 206A-
1 p.
artikel
811 N010 Low salt consumption increases plasma triglyceride despite a normal production rate Catanozi, S.
1998
11 4S1 p. 208A-
1 p.
artikel
812 N007 Modification of transmembrane cation transport systems and blood pressure by dietary calcium in men Lijnen, P.
1998
11 4S1 p. 207A-
1 p.
artikel
813 N013 Obstructive sleep apnea (OSA) is a common contributing factor to essential hypertension (EH) but is frequently undetected Silverberg, D.
1998
11 4S1 p. 209A-
1 p.
artikel
814 Nonpharmacologic intervention is effective in the treatment of obesity hypertension Lyons, R.F.
1998
11 4S1 p. 19A-
1 p.
artikel
815 Normalization of hypertensive responses during ambulatory surgical stress by perioperative music Allen, K.
1998
11 4S1 p. 19A-
1 p.
artikel
816 N004 Physicians' attitudes with respect to the treatment of hypertension Diaz, M.E.
1998
11 4S1 p. 206A-
1 p.
artikel
817 N018 Randomized, double blind trial of coenzyme Q10 in hypertensives with oxidative stress and coronary artery disease Singh, R.B.
1998
11 4S1 p. 210A-
1 p.
artikel
818 N012 Response to exercise (ex) in early hypertension and normals Gutkia, M.
1998
11 4S1 p. 208A-
1 p.
artikel
819 N002 Sodium bicarbonate and sodium chloride: Effects on blood pressure in salt-sensitive hypertensives Calvo, C.
1998
11 4S1 p. 206A-
1 p.
artikel
820 One's grandparents as a determinant of effective antihypertensive therapy Hollenberg, Norman K.
1998
11 4S1 p. 251A-
1 p.
artikel
821 Overview of JNC VI Sheps, Sheldon G.
1998
11 4S1 p. 249A-
1 p.
artikel
822 P041 A comparison of changes in cognitive function in two cohorts of men over time Robbé, I.J.
1998
11 4S1 p. 221A-
1 p.
artikel
823 P024 Acute myocardial ischaemia in hypertensive patients. Is there any relation with atmospheric pressure fluctuation? Styliadis, L.
1998
11 4S1 p. 216A-
1 p.
artikel
824 P069 Ambulatory blood pressure monitoring in passive smoking and atropine. Response in healthy volunteers Bertanelli, F.
1998
11 4S1 p. 263A-
1 p.
artikel
825 Panic attacks and panic disorder in hypertension: An important association often overlooked Davies, S.J.C.
1998
11 4S1 p. 21A-
1 p.
artikel
826 P023 Are patients well informed about hypertension and atherosclerosis? Zarifis, J.
1998
11 4S1 p. 216A-
1 p.
artikel
827 P065 Arterial hypertension as a risk factor of ischemic heart disease in old and long-living people Kipshidze, N.N.
1998
11 4S1 p. 227A-
1 p.
artikel
828 P066 Average 24-h ambulatory BP and high BP distribution in uncomplicated males and females hypertensive patients: an age-based observational study Fariello, R.
1998
11 4S1 p. 227A-
1 p.
artikel
829 P062 Blood pressure and birth weight in adolescents with different family history of hypertension Valvo, E.V.
1998
11 4S1 p. 226A-
1 p.
artikel
830 P036 Blood pressure and serum antioxidant levels: Evidence from the Scottish Health Survey (SHS) 1995 Dong, W.
1998
11 4S1 p. 219A-
1 p.
artikel
831 P053 Blood pressure control in primary and secondary care Pannarale, G.
1998
11 4S1 p. 224A-
1 p.
artikel
832 P019 Blood pressure, family cardiovascular events and diet-exercise habits in Greek adolescents Lasaridis, A.N.
1998
11 4S1 p. 215A-
1 p.
artikel
833 P031 Blood pressure reactivity and development of stable hypertension in borderline hypertensives. Role of plasma cholesterol Veronesi, M.
1998
11 4S1 p. 218A-
1 p.
artikel
834 P049 Body mass index and blood pressure in a Portuguese population. A longitudinal study Macedo, M.Espiga
1998
11 4S1 p. 223A-
1 p.
artikel
835 P016 Body weight predicts blood pressure in adolescents Pasanisi, F.
1998
11 4S1 p. 214A-
1 p.
artikel
836 P039 Change in blood pressure during the first year of life Eissa, M.A.
1998
11 4S1 p. 220A-
1 p.
artikel
837 P021 Changes in body mass index (BMI) and BP levels in a Japanese male population in a longitudinal study of one year Masuo, K.
1998
11 4S1 p. 216A-
1 p.
artikel
838 P032 Changes on arterial distensibility induced by hormonal replacement therapy in both; hypertensive and normotensive post-menopausal women: Non-invasive ambulatory assessment Calderón, A.
1998
11 4S1 p. 218A-
1 p.
artikel
839 P045 Comparative analysis of the grade of control of hypertension in the same environment. Use of two different methods of measuring blood pressure Puras, Angel
1998
11 4S1 p. 222A-
1 p.
artikel
840 P025 Detection, treatment, and control of adult hypertension in Northern Indiana Elliott, W.J.
1998
11 4S1 p. 217A-
1 p.
artikel
841 P051 Determinants of left ventricular mass in Nigerian office workers Smith, V.E.
1998
11 4S1 p. 223A-
1 p.
artikel
842 P007 Domiciliary approach to blood pressure control, management and outcomes Hammond, J.W.
1998
11 4S1 p. 212A-
1 p.
artikel
843 P047 Effects of birthplace and geographic variation in disease Lackland, D.T.
1998
11 4S1 p. 222A-
1 p.
artikel
844 P022 Effects of heart rate on cardiovascular and non-cardiovascular mortality Benetos, A.
1998
11 4S1 p. 216A-
1 p.
artikel
845 P058 Evaluating hypertension control in a large HMO Alexander, M.
1998
11 4S1 p. 225A-
1 p.
artikel
846 P050 Evolution of familial aggregation of blood pressure over 17 years in children and young adults Macedo, M.Espiga
1998
11 4S1 p. 223A-
1 p.
artikel
847 P012 Factors associated to the presence of ortostatic hypotension in an elderly hypertensive population Saez, T.
1998
11 4S1 p. 213A-
1 p.
artikel
848 P015 Heart rate is inversely related to left ventricular mass Guida, L.
1998
11 4S1 p. 214A-
1 p.
artikel
849 P046 High blood pressure treatment and outcomes in the medicaid cohort in the strokebelt Lackland, D.T.
1998
11 4S1 p. 222A-
1 p.
artikel
850 P030 Higher cardiovascular risk in nondippers in a normotensive population? — Odense school child study Lambrechtsen, J.
1998
11 4S1 p. 218A-
1 p.
artikel
851 P026 High resting end tidal CO2 association with higher resting blood pressure in older women Anderson, D.E.
1998
11 4S1 p. 217A-
1 p.
artikel
852 P052 Home, ambulatory and clinic blood pressure measurements: Reliability of blood pressure cards. Changes in the severety of hypertension Navarro, J.F.
1998
11 4S1 p. 223A-
1 p.
artikel
853 P060 Hypertension as a risk factor in old age people Fernández, M.
1998
11 4S1 p. 225A-
1 p.
artikel
854 P028 Hypertension awareness and treatment are associated with resting heart rate in a representative sample Ferrières, J.
1998
11 4S1 p. 217A-
1 p.
artikel
855 P072 Hypertension guidelines for Italian general practitioners trial: The earlier results Zaninelli, A.
1998
11 4S1 p. 264A-
1 p.
artikel
856 P068 Hypertension is common among patients with obstructive sleep apnea syndrome Kantola, I.
1998
11 4S1 p. 263A-
1 p.
artikel
857 P003 Hypertension predicts the incidence of kidney stones in men: A prospective study Cappuccio, F.P.
1998
11 4S1 p. 211A-
1 p.
artikel
858 P067 Improving blood pressure control using patient self-monitoring of blood pressure Hammond, J.W.
1998
11 4S1 p. 227A-
1 p.
artikel
859 P020 Influence of global cardiovascular risk assessment on the management of hypertension in Southwestern France — from the Monica project data Vernier, I.
1998
11 4S1 p. 215A-
1 p.
artikel
860 P043 Influence of socioeconomic and lifestyle factors on blood pressure levels. Results from a population study Puras, Angel
1998
11 4S1 p. 221A-
1 p.
artikel
861 P044 Influence of systemic hypertension on one-year mortality in severe congestive heart failure (CHF) Virion, J.M.
1998
11 4S1 p. 221A-
1 p.
artikel
862 P034 Interaction of migraine and hypertension on stroke risk Chang, C.L.
1998
11 4S1 p. 219A-
1 p.
artikel
863 Plasma homocysteine and cardiovascular risk factors in African American women Sherif, K.
1998
11 4S1 p. 25A-
1 p.
artikel
864 Plasmatic homocyst(E)ine and folate are related to arterial blood pressure in type 2 diabetes mellitus Fiorina, P.
1998
11 4S1 p. 8A-
1 p.
artikel
865 Plasma tissue inhibitor of metalloproteinase-1 is elevated in hypertension Timms, P.M.
1998
11 4S1 p. 1A-
1 p.
artikel
866 P014 Metabolic derangement in middle aged men is associated with an increase in RBC Na/Li countertransport: A 8-year follow-up study Siani, A.
1998
11 4S1 p. 214A-
1 p.
artikel
867 P033 Metabolic risk factors and target organ damage in white coat hypertensives, essential hypertensives and normotensives Abad, E.
1998
11 4S1 p. 219A-
1 p.
artikel
868 P008 Obesity and blood pressure levels in normotensive subjects in a longitudinal study Masuo, K.
1998
11 4S1 p. 212A-
1 p.
artikel
869 P010 Obesity, sympathetic hyperactivity, insulin resistance and hyperleptinemia are related with blood pressure level Masuo, K.
1998
11 4S1 p. 213A-
1 p.
artikel
870 Potential consequences of intermittent blood pressure control Leenen, F.H.H.
1998
11 4S1 p. 248A-
1 p.
artikel
871 P013 Physician's view on the adverse effects of antihypertensive drugs and prescriptional attitudes therefrom Diaz, M.E.
1998
11 4S1 p. 214A-
1 p.
artikel
872 P042 Predicting established hypertension Sechi, G.
1998
11 4S1 p. 221A-
1 p.
artikel
873 P002 Predictive value of dietary calcium on occurrence of pregnancy induced hypertension in Brazilian adolescents Fagundes, V.G.A.
1998
11 4S1 p. 211A-
1 p.
artikel
874 P054 Predictive value of the white coat effect for the development of sustained hypertension in subjects with borderline hypertension. The harvest study Palatini, P.
1998
11 4S1 p. 224A-
1 p.
artikel
875 P005 Pregnancy in hypertensive women: Differences among ethnic Lydakis, C.
1998
11 4S1 p. 212A-
1 p.
artikel
876 P001 Prevalence and correlates of repolarization abnormalities in hypertension Niarchoa, A.P.
1998
11 4S1 p. 211A-
1 p.
artikel
877 P075 Prevalence and determinants of hypertension in a community-based mass screening in Okinawa, Japan Iseki, Kunitoshi
1998
11 4S1 p. 264A-
1 p.
artikel
878 P061 Prevalence and determinents of hypertension in five Indian cities Beegom, R.
1998
11 4S1 p. 226A-
1 p.
artikel
879 P011 Prevalence of arterial hypertension in children of public schools from bragança Paulista, Brazil Machado, C.E.
1998
11 4S1 p. 213A-
1 p.
artikel
880 P040 Prevalence of echocardiographic left ventricular hypertrophy and remodeling in essential hypertensive patients in primary care: The VITAE study Coca, A.
1998
11 4S1 p. 220A-
1 p.
artikel
881 P037 Prevalence of echocardiographic patterns of left ventricular geometry in hypertensive patients: Does it depend on the diagnostic criteria applied? Bertoli, D.
1998
11 4S1 p. 220A-
1 p.
artikel
882 P071 Prevalence of hypertension in primary glomerulonephritis Laganović, M.
1998
11 4S1 p. 263A-
1 p.
artikel
883 P006 Prevalence of preeclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women Lidakis, C.
1998
11 4S1 p. 212A-
1 p.
artikel
884 P064 Prognostic implications of left ventricular geometric patterns in hypertensive patients Franceschini, L.
1998
11 4S1 p. 226A-
1 p.
artikel
885 P004 Relationship between blood pressure, body mass and adiposity in populations of different ethnic background Cappuccio, F.P.
1998
11 4S1 p. 211A-
1 p.
artikel
886 P027 Relationship between heart rate and cardiovascular risk factors in adolescents Rabbia, F.
1998
11 4S1 p. 217A-
1 p.
artikel
887 P055 Relationship of hypertension and obesity to the risk of acute myocardial infarction in a screened cohort in Okinawa, Japan Wakugami, K.
1998
11 4S1 p. 224A-
1 p.
artikel
888 P059 Renal artery stenotic changes in hypertensive patients with ischemic heart disease Lefkos, N.
1998
11 4S1 p. 225A-
1 p.
artikel
889 Prenatal calcium supplementation lowers blood pressure in children Hatton, D.C.
1998
11 4S1 p. 15A-
1 p.
artikel
890 Prevalence and cardiovascular disease-related correlates of orthostatic hypotension in middle-age: The atherosclerosis risk in communities study Rose, K.M.
1998
11 4S1 p. 21A-
1 p.
artikel
891 Prevalence, demographics, and profile of the patient with erectile dysfunction McKinlay, John B.
1998
11 4S1 p. 259A-
1 p.
artikel
892 Preventing effect of angiotensin-1 converting enzyme inhibitors on pneumonia in elderly subjects Okaishi, K.
1998
11 4S1 p. 9A-
1 p.
artikel
893 Progestogen-only contraceptives, hypertension history and stroke risk Poulter, N.R.
1998
11 4S1 p. 15A-
1 p.
artikel
894 Prognostic significance of nocturnal BP for developing microalbuminuria in IDDM Lurbe, E.
1998
11 4S1 p. 23A-
1 p.
artikel
895 P073 Salt sensitivity distribution in Chinese population and the characteristics of salt sensitive subjects with normotension Liu, Z.Q.
1998
11 4S1 p. 264A-
1 p.
artikel
896 P074 Screening for abdominal aorta aneurysm in patients with hypertension Mediavilla, J.D.
1998
11 4S1 p. 264A-
1 p.
artikel
897 P035 Socio-economic status and blood pressure; overview of published data: 1966–1996 Colhoun, H.
1998
11 4S1 p. 219A-
1 p.
artikel
898 P009 Sympathetic activity is related with hyperinsulinemia and BP levels in a Japanese population Masuo, K.
1998
11 4S1 p. 213A-
1 p.
artikel
899 P017 The correlation between renal function and age-related changes in blood pressure Fong, R.L.
1998
11 4S1 p. 215A-
1 p.
artikel
900 P057 The influence of two different normal limits of ambulatory blood pressure on the assessment of white coat hypertension and target organ damage R., Hernández-del Rey
1998
11 4S1 p. 225A-
1 p.
artikel
901 P029 The links between obesity, hypertension and diabetes: A cohort study Boumendil, E.F.
1998
11 4S1 p. 218A-
1 p.
artikel
902 P056 The prognostic importance of various parameters of electrocardiographic left ventricular hypertrophy Xie, L.D.
1998
11 4S1 p. 224A-
1 p.
artikel
903 P070 Using medication history to measure indication bias in observational studies of antihypertensive therapy risks Leader, S.
1998
11 4S1 p. 263A-
1 p.
artikel
904 P048 Value of childhood blood pressure measurements in predicting future adult elevated blood pressure Macedo, M.Espiga
1998
11 4S1 p. 222A-
1 p.
artikel
905 P063 Waist circumference and risk of hypertension in Indian urban women Singh, R.B.
1998
11 4S1 p. 226A-
1 p.
artikel
906 P018 Which obesity indicator is more associated to cardiovascular risk factors in an elderly population? Suarez, C.
1998
11 4S1 p. 215A-
1 p.
artikel
907 P038 “White-coat hypertension”. Does it produce cardiac damage in the elderly?. An echocardiographic population study Ruiz-Nodar, J.M.
1998
11 4S1 p. 220A-
1 p.
artikel
908 Q022 Bias in reporting prevalence of hypertension need further standard recommendations Chávez-Dominguez, R.
1998
11 4S1 p. 233A-
1 p.
artikel
909 Q004 Blood pressure and weight patterns in a hypertension practice: Comparison with national trends Krakoff, L.R.
1998
11 4S1 p. 228A-
1 p.
artikel
910 Q025 Capped payments for antihypertensive drug therapy: Effects in one clinic Elliott, W.J.
1998
11 4S1 p. 265A-
1 p.
artikel
911 Q019 Correlation of physical examination (PE) and two ECG criteria (ECG) to echocardiographic (ECHO) determined left ventricular hypertrophy (LVH) Carr, A.A.
1998
11 4S1 p. 232A-
1 p.
artikel
912 Q013 Doppler ultrasound to detect restenosis after percutaneous transluminal renal angioplasty (PTRA) Doyle, S.
1998
11 4S1 p. 231A-
1 p.
artikel
913 Q003 Effect of hypertension on lipid and fibrinogen levels in patients referred for dyslipidaemia Papadakis, J.A.
1998
11 4S1 p. 228A-
1 p.
artikel
914 Q009 Evaluation of patient satisfaction and desired health outcomes in hypertension care Stafford, J.L.
1998
11 4S1 p. 230A-
1 p.
artikel
915 Q011 Evolution of academic-community relationships in the development of a hypertension information program in the Southeast Cole, S.
1998
11 4S1 p. 230A-
1 p.
artikel
916 Q021 Group educational activities and control of blood pressure Jardim, P.C.V.
1998
11 4S1 p. 233A-
1 p.
artikel
917 Q012 Hypertension control and access to medical care in the inner city Kotchen, J.M.
1998
11 4S1 p. 230A-
1 p.
artikel
918 Q007 Hypertension in children: Care in diagnosis Machado, C.E.
1998
11 4S1 p. 229A-
1 p.
artikel
919 Q016 Hypertensive retinopathy: The importance of ophthalmoscopy in the assessment of target-organ damage (TOD) Hyman, B.N.
1998
11 4S1 p. 231A-
1 p.
artikel
920 Q008 Identifying patient attitudes and behaviors that affect the management of hypertension Stafford, J.L.
1998
11 4S1 p. 229A-
1 p.
artikel
921 Q018 Initial treatment of hypertension: An analysis of the first year of treatment Caro, J.
1998
11 4S1 p. 232A-
1 p.
artikel
922 Q023 Lack of impact of JNC-VI risk stratification on pharmacologic therapy in urban African-Americans Pogue, V.A.
1998
11 4S1 p. 233A-
1 p.
artikel
923 Q010 Patient temptation to discontinue antihypertensive therapy Garfield, F.B.
1998
11 4S1 p. 230A-
1 p.
artikel
924 Q020 Physicians' opinions on selected factors that often impede compliance with antihypertensive therapy Diaz, M.E.
1998
11 4S1 p. 232A-
1 p.
artikel
925 Q024 Physicians' satisfaction with hypertension (HTN) management and their role in improving patient compliance Stafford, J.L.
1998
11 4S1 p. 233A-
1 p.
artikel
926 Q017 Predictors of medication compliance in a large population of hypertensive patients Avorn, J.
1998
11 4S1 p. 232A-
1 p.
artikel
927 Q002 Prevalence and treatment of hypertensives with or without co-morbid conditions Meier, J.L.
1998
11 4S1 p. 228A-
1 p.
artikel
928 Q015 Prevalence of diabetes mellitus in systolic dysfunction Somasundaram, P.
1998
11 4S1 p. 231A-
1 p.
artikel
929 Q005 Prognostic value of hypertension for early mortality after myocardial infarction Berton, G.
1998
11 4S1 p. 229A-
1 p.
artikel
930 Q014 Revascularization vs. medical management in elderly patients with atherosclerotic renovascular disease (ARVD) Doyle, S.
1998
11 4S1 p. 231A-
1 p.
artikel
931 Q001 The answer to “What is my BP, doctor?” Depends on whom is asked Chatellier, G.
1998
11 4S1 p. 228A-
1 p.
artikel
932 Q006 Use of the internet to spread information about hypertension at the medical school and in the community Machado, C.E.
1998
11 4S1 p. 229A-
1 p.
artikel
933 Receptors Timmermans, Pieter B.M.W.M.
1998
11 4S1 p. 240A-
1 p.
artikel
934 Reduction in cardiovascular risk factors after 1 year's treatment with orlistat Zavoral, J.H.
1998
11 4S1 p. 19A-
1 p.
artikel
935 Relationship between brachial artery compliance & levels of cardiovascular risk factors in healthy young adults: The bogalusa heart study Urbina, E.M.
1998
11 4S1 p. 21A-
1 p.
artikel
936 Relationship of microalbuminuria endothelin-1, and growth factors in human essential hypertension Cottone, S.
1998
11 4S1 p. 1A-
1 p.
artikel
937 Renal protection by antihypertensive drugs: What are the issues for the new millennium? Hollenberg, Norman K.
1998
11 4S1 p. 244A-
1 p.
artikel
938 Renal vascular response to captopril in healthy humans: Variation reflects endogenous angiotensin II production Fisher, N.D.L.
1998
11 4S1 p. 30A-
1 p.
artikel
939 Renoprotective effects of antihypertensive agents Preston, R.A.
1998
11 4S1 p. 253A-
1 p.
artikel
940 Retinal renin and proliferative retinopathy Skinner, S.
1998
11 4S1 p. 236A-
1 p.
artikel
941 Risk factors and risk profiling as a basis for individualizing treatment Alderman, Michael H.
1998
11 4S1 p. 246A-
1 p.
artikel
942 Risk factors and risk profiling as a basis for individualizing treatment Alderman, Michael H.
1998
11 4S1 p. 246A-
1 p.
artikel
943 Risk stratification and thresholds for treatment: Technical aspects Cooper, Richard
1998
11 4S1 p. 242A-
1 p.
artikel
944 Role of adrenomedullin Nicholls, M.Gary
1998
11 4S1 p. 234A-
1 p.
artikel
945 Role of the renin angiotensin system and the sympathetic nervous system in the heart Gavras, Haralambos
1998
11 4S1 p. 244A-
1 p.
artikel
946 Salt sensitivity is not associated with left ventricular remodeling or hypertrophy in subjects with normal or mildly elevated blood pressure Hinderliter, A.L.
1998
11 4S1 p. 2A-
1 p.
artikel
947 Selective blockade of AT2 receptors offsets the blood pressure lowering effect of losartan in salt-restricted rats Gigante, B.
1998
11 4S1 p. 18A-
1 p.
artikel
948 Should the effect of renal function be a criterion when selecting antihypertensive therapy? Frohlich, Edward D.
1998
11 4S1 p. 256A-
1 p.
artikel
949 Sildenafil in the treatment of erectile dysfunction: Efficacy in patients taking concomitant antihypertensive therapy Feldman, R.
1998
11 4S1 p. 10A-
1 p.
artikel
950 Strategies for management of hypertension — traditional approaches and new opportunities Reid, John L.
1998
11 4S1 p. 246A-
1 p.
artikel
951 Strict blood pressure control delays the progression of nephropathy in type 2 diabetes mellitus Ward, H.J.
1998
11 4S1 p. 16A-
1 p.
artikel
952 Stroke incidence in the placebo-controlled chinese trial on isolated systolic hypertension in the elderly Lisheng, Liu
1998
11 4S1 p. 245A-
1 p.
artikel
953 Subgroup and per-protocol analysis of the European trial on isolated systolic hypertension in the elderly Staessen, J.A.
1998
11 4S1 p. 244A-
1 p.
artikel
954 Sympathoinhibitory and depressor effects of central nifedipine in SHR on high versus regular sodium intake Huang, B.S.
1998
11 4S1 p. 29A-
1 p.
artikel
955 Systolic blood pressure spontaneously decreases in the first days after ischemic stroke Fortini, A.
1998
11 4S1 p. 26A-
1 p.
artikel
956 T channels and L channels: does it make a difference? Clozel, Jean-Paul
1998
11 4S1 p. 257A-
1 p.
artikel
957 The anglo-scandinavian cardiac outcomes trial (ASCOT) Dahlof, B.
1998
11 4S1 p. 9A-
1 p.
artikel
958 The ASH special lecture comparison of the effects of ACE inhibition and AT1 receptor blockade on atherosclerosis Chobanian, Aram V.
1998
11 4S1 p. 238A-
1 p.
artikel
959 The blockade of the renin system blunts endothelial adhesin expression in vivo Ferri, C.
1998
11 4S1 p. 28A-
1 p.
artikel
960 The different impact of maternal hypertension on birthweight of whites and blacks Fang, J.
1998
11 4S1 p. 15A-
1 p.
artikel
961 The dominant role of systolic blood pressure as a risk factor for cardiovascular disease Levy, Daniel
1998
11 4S1 p. 253A-
1 p.
artikel
962 The effect of melatonin on the circadian rhythm of blood pressure in shift workers Reisin, L.
1998
11 4S1 p. 4A-
1 p.
artikel
963 The fosinopril amlodipine cardiovascular events trial (FACET) and new evidence on antihypertensive treatments in diabetics Pahor, M.
1998
11 4S1 p. 245A-
1 p.
artikel
964 The genomics revolution and its implications for new drug discovery Austin, Christopher P.
1998
11 4S1 p. 242A-
1 p.
artikel
965 The hemodynamic and hormonal effects of AT1 receptor blockade added to ACE inhibition in heart failure Baruch, Lawrence
1998
11 4S1 p. 252A-
1 p.
artikel
966 The HOT study Hansson, Lennart
1998
11 4S1 p. 244A-
1 p.
artikel
967 The human genome project: Implications for hypertension Smith, Cassandra L.
1998
11 4S1 p. 243A-
1 p.
artikel
968 The hypertension syndrome Neutel, Joel M.
1998
11 4S1 p. 258A-
1 p.
artikel
969 The impact of cardiovascular drugs on sexual function Grimm Jr, Richard H.
1998
11 4S1 p. 257A-
1 p.
artikel
970 The importance of ambulatory BP monitoring in evaluating the effects of hypertension on the heart Massie, Barry M.
1998
11 4S1 p. 258A-
1 p.
artikel
971 The influence of potassium on ambulatory blood pressure non-dipping status in salt-sensitive versus salt-resistant black adolescents Wilson, D.K.
1998
11 4S1 p. 17A-
1 p.
artikel
972 The management of hypertension and other complications in diabetic and obese patients Tuck, Michael L.
1998
11 4S1 p. 251A-
1 p.
artikel
973 The pharmacokinetics of angiotensin II receptor blockers (ARBS): Are they different? Zusman, R.M.
1998
11 4S1 p. 258A-
1 p.
artikel
974 Therapeutic coverage with angiotensin II antagonists Weir, M.R.
1998
11 4S1 p. 249A-
1 p.
artikel
975 The role of combination therapy per JNC VI Neutel, Joel M.
1998
11 4S1 p. 249A-
1 p.
artikel
976 The sixth joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Sheldon, G.
1998
11 4S1 p. 234A-
1 p.
artikel
977 Transcapillary leakage of albumin and forearm responsiveness to acetylcholine in hypertensives and atherosclerotic patients Penno, G.
1998
11 4S1 p. 28A-
1 p.
artikel
978 Triggering and circadian variation of cardiovascular disease Muller, James E.
1998
11 4S1 p. 254A-
1 p.
artikel
979 Ultrasonic myocardial texture and hyperinsulinemia in essential hypertension Di Bello, V.
1998
11 4S1 p. 22A-
1 p.
artikel
980 Use of calcium antagonists and risk of pulmonary embolism in older patients with hip fracture Zuccalà, G.
1998
11 4S1 p. 4A-
1 p.
artikel
981 Value of combination therapy for patients with renal disease Bakris, George
1998
11 4S1 p. 249A-
1 p.
artikel
982 Waist-to-hip ratio is a better predictor for hypertensive syndrome than body mass index in Brazilian obese subjects Torres, M.R.S.G.
1998
11 4S1 p. 22A-
1 p.
artikel
983 White blood cells (WBC) and coronary atherosclerotic disease (C.A.D.) Restori, G.
1998
11 4S1 p. 20A-
1 p.
artikel
984 Women are different from men in affairs of the heart Wassertheil-Smoller, Sylvia
1998
11 4S1 p. 239A-
1 p.
artikel
                             984 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland